# Business Requirements Document (BRD)

# ‡πÄ‡∏≠‡∏Å‡∏™‡∏≤‡∏£‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡∏ó‡∏≤‡∏á‡∏ò‡∏∏‡∏£‡∏Å‡∏¥‡∏à

**INVS Modern - Hospital Inventory Management System**  
**‡∏£‡∏∞‡∏ö‡∏ö‡∏ö‡∏£‡∏¥‡∏´‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏û‡∏±‡∏™‡∏î‡∏∏‡∏¢‡∏≤‡πÅ‡∏•‡∏∞‡πÄ‡∏ß‡∏ä‡∏†‡∏±‡∏ì‡∏ë‡πå‡πÇ‡∏£‡∏á‡∏û‡∏¢‡∏≤‡∏ö‡∏≤‡∏•**

---

## Document Information | ‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡πÄ‡∏≠‡∏Å‡∏™‡∏≤‡∏£

| Field                | Value                        |
| -------------------- | ---------------------------- |
| **Document Version** | 1.0.0                        |
| **Date Created**     | 2025-01-22                   |
| **Last Updated**     | 2025-01-22                   |
| **Status**           | Draft for Review             |
| **Prepared By**      | INVS Modern Development Team |
| **Approved By**      | [Pending Approval]           |

---

## Table of Contents | ‡∏™‡∏≤‡∏£‡∏ö‡∏±‡∏ç

1. [Executive Summary](#1-executive-summary--‡∏ö‡∏ó‡∏™‡∏£‡∏∏‡∏õ‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏ú‡∏π‡πâ‡∏ö‡∏£‡∏¥‡∏´‡∏≤‡∏£)
2. [Project Information](#2-project-information--‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡πÇ‡∏Ñ‡∏£‡∏á‡∏Å‡∏≤‡∏£)
3. [Business Overview](#3-business-overview--‡∏†‡∏≤‡∏û‡∏£‡∏ß‡∏°‡∏ò‡∏∏‡∏£‡∏Å‡∏¥‡∏à)
4. [Problems and Requirements](#4-problems-and-requirements--‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡πÅ‡∏•‡∏∞‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£)
5. [Project Scope](#5-project-scope--‡∏Ç‡∏≠‡∏ö‡πÄ‡∏Ç‡∏ï‡πÇ‡∏Ñ‡∏£‡∏á‡∏Å‡∏≤‡∏£)
6. [Functional Requirements](#6-functional-requirements--‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡∏î‡πâ‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡∏ó‡∏≥‡∏á‡∏≤‡∏ô)
7. [Business Rules](#7-business-rules--‡∏Å‡∏é‡∏ó‡∏≤‡∏á‡∏ò‡∏∏‡∏£‡∏Å‡∏¥‡∏à)
8. [Compliance Requirements](#8-compliance-requirements--‡∏Ç‡πâ‡∏≠‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡∏î‡πâ‡∏≤‡∏ô‡∏Å‡∏é‡∏£‡∏∞‡πÄ‡∏ö‡∏µ‡∏¢‡∏ö)
9. [User Roles and Permissions](#9-user-roles-and-permissions--‡∏ö‡∏ó‡∏ö‡∏≤‡∏ó‡πÅ‡∏•‡∏∞‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡πå‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ)
10. [Success Criteria](#10-success-criteria--‡πÄ‡∏Å‡∏ì‡∏ë‡πå‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡πÄ‡∏£‡πá‡∏à)
11. [Assumptions and Constraints](#11-assumptions-and-constraints--‡∏™‡∏°‡∏°‡∏ï‡∏¥‡∏ê‡∏≤‡∏ô‡πÅ‡∏•‡∏∞‡∏Ç‡πâ‡∏≠‡∏à‡∏≥‡∏Å‡∏±‡∏î)
12. [Risks and Mitigation](#12-risks-and-mitigation--‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏ö‡∏£‡∏¥‡∏´‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£)
13. [Appendices](#13-appendices--‡∏†‡∏≤‡∏Ñ‡∏ú‡∏ô‡∏ß‡∏Å)

---

## 1. Executive Summary | ‡∏ö‡∏ó‡∏™‡∏£‡∏∏‡∏õ‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏ú‡∏π‡πâ‡∏ö‡∏£‡∏¥‡∏´‡∏≤‡∏£

### 1.1 Purpose | ‡∏ß‡∏±‡∏ï‡∏ñ‡∏∏‡∏õ‡∏£‡∏∞‡∏™‡∏á‡∏Ñ‡πå

**English:**  
INVS Modern is a comprehensive hospital inventory management system designed to modernize and streamline drug and medical supply procurement, inventory control, and distribution processes. This system replaces the legacy INVS system with a modern, scalable, and compliant solution.

**‡∏†‡∏≤‡∏©‡∏≤‡πÑ‡∏ó‡∏¢:**  
INVS Modern ‡πÄ‡∏õ‡πá‡∏ô‡∏£‡∏∞‡∏ö‡∏ö‡∏ö‡∏£‡∏¥‡∏´‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏û‡∏±‡∏™‡∏î‡∏∏‡∏¢‡∏≤‡πÅ‡∏•‡∏∞‡πÄ‡∏ß‡∏ä‡∏†‡∏±‡∏ì‡∏ë‡πå‡πÇ‡∏£‡∏á‡∏û‡∏¢‡∏≤‡∏ö‡∏≤‡∏•‡πÅ‡∏ö‡∏ö‡∏Ñ‡∏£‡∏ö‡∏ß‡∏á‡∏à‡∏£ ‡∏≠‡∏≠‡∏Å‡πÅ‡∏ö‡∏ö‡∏°‡∏≤‡πÄ‡∏û‡∏∑‡πà‡∏≠‡∏û‡∏±‡∏í‡∏ô‡∏≤‡πÅ‡∏•‡∏∞‡∏õ‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∏‡∏á‡∏Å‡∏£‡∏∞‡∏ö‡∏ß‡∏ô‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠ ‡∏Å‡∏≤‡∏£‡∏Ñ‡∏ß‡∏ö‡∏Ñ‡∏∏‡∏°‡∏™‡∏ï‡πá‡∏≠‡∏Å ‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤ ‡πÇ‡∏î‡∏¢‡∏à‡∏∞‡∏ó‡∏î‡πÅ‡∏ó‡∏ô‡∏£‡∏∞‡∏ö‡∏ö INVS ‡πÄ‡∏î‡∏¥‡∏°‡∏î‡πâ‡∏ß‡∏¢‡πÇ‡∏ã‡∏•‡∏π‡∏ä‡∏±‡∏ô‡∏ó‡∏µ‡πà‡∏ó‡∏±‡∏ô‡∏™‡∏°‡∏±‡∏¢ ‡∏£‡∏≠‡∏á‡∏£‡∏±‡∏ö‡∏Å‡∏≤‡∏£‡∏Ç‡∏¢‡∏≤‡∏¢‡∏á‡∏≤‡∏ô ‡πÅ‡∏•‡∏∞‡∏™‡∏≠‡∏î‡∏Ñ‡∏•‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ö‡∏°‡∏≤‡∏ï‡∏£‡∏ê‡∏≤‡∏ô‡∏ó‡∏µ‡πà‡∏Å‡∏≥‡∏´‡∏ô‡∏î

### 1.2 Business Objectives | ‡∏ß‡∏±‡∏ï‡∏ñ‡∏∏‡∏õ‡∏£‡∏∞‡∏™‡∏á‡∏Ñ‡πå‡∏ó‡∏≤‡∏á‡∏ò‡∏∏‡∏£‡∏Å‡∏¥‡∏à

1. **Improve Budget Control** | **‡∏õ‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∏‡∏á‡∏Å‡∏≤‡∏£‡∏Ñ‡∏ß‡∏ö‡∏Ñ‡∏∏‡∏°‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì**
   - Real-time budget checking and reservation system
   - ‡∏£‡∏∞‡∏ö‡∏ö‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡πÅ‡∏•‡∏∞‡∏à‡∏≠‡∏á‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡πÅ‡∏ö‡∏ö‡∏ó‡∏±‡∏ô‡∏ó‡∏µ
   - Quarterly budget allocation and monitoring
   - ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏™‡∏£‡∏£‡πÅ‡∏•‡∏∞‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏£‡∏≤‡∏¢‡πÑ‡∏ï‡∏£‡∏°‡∏≤‡∏™

2. **Enhance Inventory Accuracy** | **‡πÄ‡∏û‡∏¥‡πà‡∏°‡∏Ñ‡∏ß‡∏≤‡∏°‡πÅ‡∏°‡πà‡∏ô‡∏¢‡∏≥‡∏Ç‡∏≠‡∏á‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤**
   - FIFO/FEFO lot tracking to minimize waste
   - ‡∏£‡∏∞‡∏ö‡∏ö‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏•‡πá‡∏≠‡∏ï‡πÅ‡∏ö‡∏ö FIFO/FEFO ‡πÄ‡∏û‡∏∑‡πà‡∏≠‡∏•‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏π‡∏ç‡πÄ‡∏™‡∏µ‡∏¢
   - Multi-location inventory management
   - ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏ï‡πá‡∏≠‡∏Å‡πÅ‡∏ö‡∏ö‡∏´‡∏•‡∏≤‡∏¢‡∏™‡∏ñ‡∏≤‡∏ô‡∏ó‡∏µ‡πà

3. **Ensure Ministry Compliance** | **‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∞‡∏Å‡∏±‡∏ô‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≠‡∏î‡∏Ñ‡∏•‡πâ‡∏≠‡∏á‡∏ï‡∏≤‡∏°‡∏Ç‡πâ‡∏≠‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡∏Ç‡∏≠‡∏á‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á**
   - 100% compliance with DMSIC Standards ‡∏û.‡∏®. 2568
   - ‡∏™‡∏≠‡∏î‡∏Ñ‡∏•‡πâ‡∏≠‡∏á‡∏ï‡∏≤‡∏°‡∏°‡∏≤‡∏ï‡∏£‡∏ê‡∏≤‡∏ô DMSIC ‡∏û.‡∏®. 2568 ‡∏Ñ‡∏£‡∏ö 100%
   - 5 mandatory export files for Ministry of Public Health
   - ‡πÑ‡∏ü‡∏•‡πå‡∏™‡πà‡∏á‡∏≠‡∏≠‡∏Å 5 ‡πÑ‡∏ü‡∏•‡πå‡∏ï‡∏≤‡∏°‡∏ó‡∏µ‡πà‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏™‡∏≤‡∏ò‡∏≤‡∏£‡∏ì‡∏™‡∏∏‡∏Ç‡∏Å‡∏≥‡∏´‡∏ô‡∏î

4. **Streamline Procurement Process** | **‡∏õ‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∏‡∏á‡∏Å‡∏£‡∏∞‡∏ö‡∏ß‡∏ô‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠**
   - Automated purchase request workflows
   - ‡∏£‡∏∞‡∏ö‡∏ö‡∏Ç‡∏≠‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥‡∏ã‡∏∑‡πâ‡∏≠‡πÅ‡∏ö‡∏ö‡∏≠‡∏±‡∏ï‡πÇ‡∏ô‡∏°‡∏±‡∏ï‡∏¥
   - Integration with contract management
   - ‡∏ö‡∏π‡∏£‡∏ì‡∏≤‡∏Å‡∏≤‡∏£‡∏Å‡∏±‡∏ö‡∏£‡∏∞‡∏ö‡∏ö‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏±‡∏ç‡∏ç‡∏≤

5. **Support Data-Driven Decisions** | **‡∏™‡∏ô‡∏±‡∏ö‡∏™‡∏ô‡∏∏‡∏ô‡∏Å‡∏≤‡∏£‡∏ï‡∏±‡∏î‡∏™‡∏¥‡∏ô‡πÉ‡∏à‡πÇ‡∏î‡∏¢‡∏≠‡∏≤‡∏®‡∏±‡∏¢‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•**
   - Comprehensive reporting and analytics
   - ‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏ß‡∏¥‡πÄ‡∏Ñ‡∏£‡∏≤‡∏∞‡∏´‡πå‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏ó‡∏µ‡πà‡∏Ñ‡∏£‡∏≠‡∏ö‡∏Ñ‡∏•‡∏∏‡∏°
   - Drug usage pattern analysis (ABC-VEN)
   - ‡∏Å‡∏≤‡∏£‡∏ß‡∏¥‡πÄ‡∏Ñ‡∏£‡∏≤‡∏∞‡∏´‡πå‡∏£‡∏π‡∏õ‡πÅ‡∏ö‡∏ö‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏¢‡∏≤ (ABC-VEN)

### 1.3 Expected Benefits | ‡∏õ‡∏£‡∏∞‡πÇ‡∏¢‡∏ä‡∏ô‡πå‡∏ó‡∏µ‡πà‡∏Ñ‡∏≤‡∏î‡∏ß‡πà‡∏≤‡∏à‡∏∞‡πÑ‡∏î‡πâ‡∏£‡∏±‡∏ö

**Operational Benefits | ‡∏õ‡∏£‡∏∞‡πÇ‡∏¢‡∏ä‡∏ô‡πå‡∏î‡πâ‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡∏î‡∏≥‡πÄ‡∏ô‡∏¥‡∏ô‡∏á‡∏≤‡∏ô:**

- ‚è±Ô∏è 50% reduction in purchase request processing time
- ‚è±Ô∏è ‡∏•‡∏î‡πÄ‡∏ß‡∏•‡∏≤‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏õ‡∏£‡∏∞‡∏°‡∏ß‡∏•‡∏ú‡∏•‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠‡∏•‡∏á 50%
- üìâ 30% reduction in expired drug waste
- üìâ ‡∏•‡∏î‡∏Ç‡∏≠‡∏á‡πÄ‡∏™‡∏µ‡∏¢‡∏à‡∏≤‡∏Å‡∏¢‡∏≤‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏•‡∏á 30%
- üí∞ 20% improvement in budget utilization
- üí∞ ‡πÄ‡∏û‡∏¥‡πà‡∏°‡∏õ‡∏£‡∏∞‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡∏†‡∏≤‡∏û‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏Ç‡∏∂‡πâ‡∏ô 20%

**Compliance Benefits | ‡∏õ‡∏£‡∏∞‡πÇ‡∏¢‡∏ä‡∏ô‡πå‡∏î‡πâ‡∏≤‡∏ô‡∏Å‡∏é‡∏£‡∏∞‡πÄ‡∏ö‡∏µ‡∏¢‡∏ö:**

- ‚úÖ 100% accurate ministry reporting
- ‚úÖ ‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏ñ‡∏π‡∏Å‡∏ï‡πâ‡∏≠‡∏á‡πÅ‡∏°‡πà‡∏ô‡∏¢‡∏≥ 100%
- üîê Full audit trail for all transactions
- üîê ‡∏°‡∏µ‡∏£‡πà‡∏≠‡∏á‡∏£‡∏≠‡∏¢‡∏Å‡∏≤‡∏£‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡∏Ñ‡∏£‡∏ö‡∏ñ‡πâ‡∏ß‡∏ô‡∏ó‡∏∏‡∏Å‡∏ò‡∏∏‡∏£‡∏Å‡∏£‡∏£‡∏°

**Strategic Benefits | ‡∏õ‡∏£‡∏∞‡πÇ‡∏¢‡∏ä‡∏ô‡πå‡πÄ‡∏ä‡∏¥‡∏á‡∏Å‡∏•‡∏¢‡∏∏‡∏ó‡∏ò‡πå:**

- üìä Better demand forecasting and planning
- üìä ‡∏Å‡∏≤‡∏£‡∏Ñ‡∏≤‡∏î‡∏Å‡∏≤‡∏£‡∏ì‡πå‡πÅ‡∏•‡∏∞‡∏ß‡∏≤‡∏á‡πÅ‡∏ú‡∏ô‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡∏ó‡∏µ‡πà‡∏î‡∏µ‡∏Ç‡∏∂‡πâ‡∏ô
- üîÑ Improved vendor relationship management
- üîÑ ‡∏Å‡∏≤‡∏£‡∏ö‡∏£‡∏¥‡∏´‡∏≤‡∏£‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏±‡∏°‡∏û‡∏±‡∏ô‡∏ò‡πå‡∏Å‡∏±‡∏ö‡∏ú‡∏π‡πâ‡∏Ç‡∏≤‡∏¢‡∏ó‡∏µ‡πà‡∏î‡∏µ‡∏Ç‡∏∂‡πâ‡∏ô

---

## 2. Project Information | ‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡πÇ‡∏Ñ‡∏£‡∏á‡∏Å‡∏≤‡∏£

### 2.1 Project Timeline | ‡∏£‡∏∞‡∏¢‡∏∞‡πÄ‡∏ß‡∏•‡∏≤‡πÇ‡∏Ñ‡∏£‡∏á‡∏Å‡∏≤‡∏£

| Phase                             | Duration | Status            |
| --------------------------------- | -------- | ----------------- |
| **Phase 1: Database & Schema**    | 3 months | ‚úÖ Complete       |
| ‡∏£‡∏∞‡∏¢‡∏∞‡∏ó‡∏µ‡πà 1: ‡∏ê‡∏≤‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡πÅ‡∏•‡∏∞‡πÇ‡∏Ñ‡∏£‡∏á‡∏™‡∏£‡πâ‡∏≤‡∏á  | 3 ‡πÄ‡∏î‡∏∑‡∏≠‡∏ô  | ‡πÄ‡∏™‡∏£‡πá‡∏à‡∏™‡∏°‡∏ö‡∏π‡∏£‡∏ì‡πå      |
| **Phase 2: Backend API**          | 4 months | üöß Planned        |
| ‡∏£‡∏∞‡∏¢‡∏∞‡∏ó‡∏µ‡πà 2: Backend API            | 4 ‡πÄ‡∏î‡∏∑‡∏≠‡∏ô  | ‡∏≠‡∏¢‡∏π‡πà‡∏£‡∏∞‡∏´‡∏ß‡πà‡∏≤‡∏á‡∏ß‡∏≤‡∏á‡πÅ‡∏ú‡∏ô |
| **Phase 3: Frontend Application** | 5 months | üöß Planned        |
| ‡∏£‡∏∞‡∏¢‡∏∞‡∏ó‡∏µ‡πà 3: ‡∏™‡πà‡∏ß‡∏ô‡πÅ‡∏™‡∏î‡∏á‡∏ú‡∏•‡∏î‡πâ‡∏≤‡∏ô‡∏´‡∏ô‡πâ‡∏≤     | 5 ‡πÄ‡∏î‡∏∑‡∏≠‡∏ô  | ‡∏≠‡∏¢‡∏π‡πà‡∏£‡∏∞‡∏´‡∏ß‡πà‡∏≤‡∏á‡∏ß‡∏≤‡∏á‡πÅ‡∏ú‡∏ô |
| **Phase 4: Testing & Deployment** | 2 months | üöß Planned        |
| ‡∏£‡∏∞‡∏¢‡∏∞‡∏ó‡∏µ‡πà 4: ‡∏ó‡∏î‡∏™‡∏≠‡∏ö‡πÅ‡∏•‡∏∞‡∏ô‡∏≥‡πÑ‡∏õ‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô     | 2 ‡πÄ‡∏î‡∏∑‡∏≠‡∏ô  | ‡∏≠‡∏¢‡∏π‡πà‡∏£‡∏∞‡∏´‡∏ß‡πà‡∏≤‡∏á‡∏ß‡∏≤‡∏á‡πÅ‡∏ú‡∏ô |

**Total Project Duration:** 14 months  
**‡∏£‡∏∞‡∏¢‡∏∞‡πÄ‡∏ß‡∏•‡∏≤‡πÇ‡∏Ñ‡∏£‡∏á‡∏Å‡∏≤‡∏£‡∏ó‡∏±‡πâ‡∏á‡∏´‡∏°‡∏î:** 14 ‡πÄ‡∏î‡∏∑‡∏≠‡∏ô

### 2.2 Project Stakeholders | ‡∏ú‡∏π‡πâ‡∏°‡∏µ‡∏™‡πà‡∏ß‡∏ô‡πÑ‡∏î‡πâ‡∏™‡πà‡∏ß‡∏ô‡πÄ‡∏™‡∏µ‡∏¢

**Primary Stakeholders | ‡∏ú‡∏π‡πâ‡∏°‡∏µ‡∏™‡πà‡∏ß‡∏ô‡πÑ‡∏î‡πâ‡∏™‡πà‡∏ß‡∏ô‡πÄ‡∏™‡∏µ‡∏¢‡∏´‡∏•‡∏±‡∏Å:**

- üè• Hospital Management (‡∏ú‡∏π‡πâ‡∏ö‡∏£‡∏¥‡∏´‡∏≤‡∏£‡πÇ‡∏£‡∏á‡∏û‡∏¢‡∏≤‡∏ö‡∏≤‡∏•)
- üíä Pharmacy Department (‡πÅ‡∏ú‡∏ô‡∏Å‡πÄ‡∏†‡∏™‡∏±‡∏ä‡∏Å‡∏£‡∏£‡∏°)
- üí∞ Finance Department (‡πÅ‡∏ú‡∏ô‡∏Å‡∏Å‡∏≤‡∏£‡πÄ‡∏á‡∏¥‡∏ô)
- üì¶ Procurement Department (‡πÅ‡∏ú‡∏ô‡∏Å‡∏û‡∏±‡∏™‡∏î‡∏∏‡πÅ‡∏•‡∏∞‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠)
- üè• Clinical Departments (‡πÅ‡∏ú‡∏ô‡∏Å‡∏Ñ‡∏•‡∏¥‡∏ô‡∏¥‡∏Å)

**Secondary Stakeholders | ‡∏ú‡∏π‡πâ‡∏°‡∏µ‡∏™‡πà‡∏ß‡∏ô‡πÑ‡∏î‡πâ‡∏™‡πà‡∏ß‡∏ô‡πÄ‡∏™‡∏µ‡∏¢‡∏£‡∏≠‡∏á:**

- üìã Ministry of Public Health (‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏™‡∏≤‡∏ò‡∏≤‡∏£‡∏ì‡∏™‡∏∏‡∏Ç)
- üè¢ Vendors and Suppliers (‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢‡πÅ‡∏•‡∏∞‡∏ú‡∏π‡πâ‡∏à‡∏±‡∏î‡∏´‡∏≤‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤)
- üë®‚Äçüíª IT Department (‡πÅ‡∏ú‡∏ô‡∏Å‡πÄ‡∏ó‡∏Ñ‡πÇ‡∏ô‡πÇ‡∏•‡∏¢‡∏µ‡∏™‡∏≤‡∏£‡∏™‡∏ô‡πÄ‡∏ó‡∏®)

### 2.3 Budget Overview | ‡∏†‡∏≤‡∏û‡∏£‡∏ß‡∏°‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì

| Category                 | Estimated Cost |
| ------------------------ | -------------- |
| **Software Development** | [TBD]          |
| ‡∏Å‡∏≤‡∏£‡∏û‡∏±‡∏í‡∏ô‡∏≤‡∏ã‡∏≠‡∏ü‡∏ï‡πå‡πÅ‡∏ß‡∏£‡πå        |                |
| **Infrastructure**       | [TBD]          |
| ‡πÇ‡∏Ñ‡∏£‡∏á‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏û‡∏∑‡πâ‡∏ô‡∏ê‡∏≤‡∏ô         |                |
| **Training & Support**   | [TBD]          |
| ‡∏Å‡∏≤‡∏£‡∏ù‡∏∂‡∏Å‡∏≠‡∏ö‡∏£‡∏°‡πÅ‡∏•‡∏∞‡∏™‡∏ô‡∏±‡∏ö‡∏™‡∏ô‡∏∏‡∏ô    |                |
| **Maintenance (Year 1)** | [TBD]          |
| ‡∏Å‡∏≤‡∏£‡∏ö‡∏≥‡∏£‡∏∏‡∏á‡∏£‡∏±‡∏Å‡∏©‡∏≤ (‡∏õ‡∏µ‡πÅ‡∏£‡∏Å)    |                |

---

## 3. Business Overview | ‡∏†‡∏≤‡∏û‡∏£‡∏ß‡∏°‡∏ò‡∏∏‡∏£‡∏Å‡∏¥‡∏à

### 3.1 Current Environment | ‡∏™‡∏†‡∏≤‡∏û‡πÅ‡∏ß‡∏î‡∏•‡πâ‡∏≠‡∏°‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô

**Legacy System | ‡∏£‡∏∞‡∏ö‡∏ö‡πÄ‡∏î‡∏¥‡∏°:**

- Name: INVS (Inventory Management System)
- ‡∏ä‡∏∑‡πà‡∏≠: ‡∏£‡∏∞‡∏ö‡∏ö‡∏ö‡∏£‡∏¥‡∏´‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏û‡∏±‡∏™‡∏î‡∏∏ INVS
- Database: MySQL (133 tables)
- ‡∏ê‡∏≤‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•: MySQL (133 ‡∏ï‡∏≤‡∏£‡∏≤‡∏á)
- Age: 10+ years
- ‡∏≠‡∏≤‡∏¢‡∏∏‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô: ‡∏°‡∏≤‡∏Å‡∏Å‡∏ß‡πà‡∏≤ 10 ‡∏õ‡∏µ
- Status: Outdated, difficult to maintain, lacks modern features
- ‡∏™‡∏ñ‡∏≤‡∏ô‡∏∞: ‡∏•‡πâ‡∏≤‡∏™‡∏°‡∏±‡∏¢ ‡∏ö‡∏≥‡∏£‡∏∏‡∏á‡∏£‡∏±‡∏Å‡∏©‡∏≤‡∏¢‡∏≤‡∏Å ‡∏Ç‡∏≤‡∏î‡∏ü‡∏µ‡πÄ‡∏à‡∏≠‡∏£‡πå‡∏ó‡∏µ‡πà‡∏ó‡∏±‡∏ô‡∏™‡∏°‡∏±‡∏¢

**Key Challenges with Legacy System | ‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏´‡∏•‡∏±‡∏Å‡∏Ç‡∏≠‡∏á‡∏£‡∏∞‡∏ö‡∏ö‡πÄ‡∏î‡∏¥‡∏°:**

1. **No Real-time Budget Control**
   - ‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡∏Ñ‡∏ß‡∏ö‡∏Ñ‡∏∏‡∏°‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡πÅ‡∏ö‡∏ö‡∏ó‡∏±‡∏ô‡∏ó‡∏µ
   - Budget overruns are common
   - ‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡πÄ‡∏Å‡∏¥‡∏ô‡∏à‡∏≥‡∏ô‡∏ß‡∏ô‡∏ó‡∏µ‡πà‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡πÄ‡∏Å‡∏¥‡∏î‡∏Ç‡∏∂‡πâ‡∏ô‡∏ö‡πà‡∏≠‡∏¢

2. **Limited Contract Management**
   - ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏±‡∏ç‡∏ç‡∏≤‡∏°‡∏µ‡∏Ç‡πâ‡∏≠‡∏à‡∏≥‡∏Å‡∏±‡∏î
   - No integration with procurement workflow
   - ‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡πÇ‡∏¢‡∏á‡∏Å‡∏±‡∏ö‡∏Å‡∏£‡∏∞‡∏ö‡∏ß‡∏ô‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠

3. **Manual Ministry Reporting**
   - ‡∏Å‡∏≤‡∏£‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡πÉ‡∏´‡πâ‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏ó‡∏≥‡∏î‡πâ‡∏ß‡∏¢‡∏°‡∏∑‡∏≠
   - Time-consuming and error-prone
   - ‡πÉ‡∏ä‡πâ‡πÄ‡∏ß‡∏•‡∏≤‡∏°‡∏≤‡∏Å‡πÅ‡∏•‡∏∞‡πÄ‡∏Å‡∏¥‡∏î‡∏Ç‡πâ‡∏≠‡∏ú‡∏¥‡∏î‡∏û‡∏•‡∏≤‡∏î‡πÑ‡∏î‡πâ‡∏á‡πà‡∏≤‡∏¢

4. **Weak Inventory Tracking**
   - ‡∏Å‡∏≤‡∏£‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏™‡∏ï‡πá‡∏≠‡∏Å‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏õ‡∏£‡∏∞‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡∏†‡∏≤‡∏û
   - Lot tracking is incomplete
   - ‡∏Å‡∏≤‡∏£‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏•‡πá‡∏≠‡∏ï‡πÑ‡∏°‡πà‡∏Ñ‡∏£‡∏ö‡∏ñ‡πâ‡∏ß‡∏ô
   - Expiry management is manual
   - ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏ß‡∏±‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏ó‡∏≥‡∏î‡πâ‡∏ß‡∏¢‡∏°‡∏∑‡∏≠

5. **No Mobile Access**
   - ‡πÑ‡∏°‡πà‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡πÄ‡∏Ç‡πâ‡∏≤‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô‡∏ú‡πà‡∏≤‡∏ô‡∏°‡∏∑‡∏≠‡∏ñ‡∏∑‡∏≠‡πÑ‡∏î‡πâ
   - Desktop-only system
   - ‡∏£‡∏∞‡∏ö‡∏ö‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô‡πÑ‡∏î‡πâ‡πÄ‡∏â‡∏û‡∏≤‡∏∞‡∏Ñ‡∏≠‡∏°‡∏û‡∏¥‡∏ß‡πÄ‡∏ï‡∏≠‡∏£‡πå‡∏ï‡∏±‡πâ‡∏á‡πÇ‡∏ï‡πä‡∏∞‡πÄ‡∏ó‡πà‡∏≤‡∏ô‡∏±‡πâ‡∏ô

### 3.2 Business Processes | ‡∏Å‡∏£‡∏∞‡∏ö‡∏ß‡∏ô‡∏Å‡∏≤‡∏£‡∏ó‡∏≤‡∏á‡∏ò‡∏∏‡∏£‡∏Å‡∏¥‡∏à

**Core Business Processes | ‡∏Å‡∏£‡∏∞‡∏ö‡∏ß‡∏ô‡∏Å‡∏≤‡∏£‡∏ó‡∏≤‡∏á‡∏ò‡∏∏‡∏£‡∏Å‡∏¥‡∏à‡∏´‡∏•‡∏±‡∏Å:**

```
1. Budget Planning (‡∏Å‡∏≤‡∏£‡∏ß‡∏≤‡∏á‡πÅ‡∏ú‡∏ô‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì)
   ‚îî‚îÄ> Annual allocation ‚Üí Quarterly breakdown ‚Üí Department assignment

2. Procurement (‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠)
   ‚îî‚îÄ> Need identification ‚Üí Budget check ‚Üí PR creation ‚Üí Approval ‚Üí PO ‚Üí Receive goods

3. Inventory Management (‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏ï‡πá‡∏≠‡∏Å)
   ‚îî‚îÄ> Receive ‚Üí Store ‚Üí Track lot/expiry ‚Üí Dispense (FIFO/FEFO) ‚Üí Reorder

4. Distribution (‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢)
   ‚îî‚îÄ> Department request ‚Üí Check stock ‚Üí Pick lot (FEFO) ‚Üí Issue ‚Üí Record

5. Reporting (‡∏Å‡∏≤‡∏£‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô)
   ‚îî‚îÄ> Daily operations ‚Üí Monthly summary ‚Üí Quarterly review ‚Üí Ministry submission
```

### 3.3 Business Volume | ‡∏õ‡∏£‡∏¥‡∏°‡∏≤‡∏ì‡∏ò‡∏∏‡∏£‡∏Å‡∏¥‡∏à

**Estimated Transaction Volume | ‡∏õ‡∏£‡∏¥‡∏°‡∏≤‡∏ì‡∏ò‡∏∏‡∏£‡∏Å‡∏£‡∏£‡∏°‡πÇ‡∏î‡∏¢‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì:**

| Transaction Type      | Daily | Monthly | Yearly       |
| --------------------- | ----- | ------- | ------------ |
| Purchase Requests     | 10-15 | 300-450 | 3,600-5,400  |
| ‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠              | 10-15 | 300-450 | 3,600-5,400  |
| Goods Receipts        | 5-10  | 150-300 | 1,800-3,600  |
| ‡πÉ‡∏ö‡∏£‡∏±‡∏ö‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤           | 5-10  | 150-300 | 1,800-3,600  |
| Drug Distributions    | 20-30 | 600-900 | 7,200-10,800 |
| ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤          | 20-30 | 600-900 | 7,200-10,800 |
| Inventory Adjustments | 2-5   | 60-150  | 720-1,800    |
| ‡∏Å‡∏≤‡∏£‡∏õ‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∏‡∏á‡∏™‡∏ï‡πá‡∏≠‡∏Å      | 2-5   | 60-150  | 720-1,800    |

**Master Data Volume | ‡∏õ‡∏£‡∏¥‡∏°‡∏≤‡∏ì‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏´‡∏•‡∏±‡∏Å:**

- Drug Generics: ~1,100 items (‡∏¢‡∏≤‡∏ä‡∏∑‡πà‡∏≠‡∏™‡∏≤‡∏°‡∏±‡∏ç)
- Trade Drugs: ~1,200 items (‡∏¢‡∏≤‡∏ä‡∏∑‡πà‡∏≠‡∏Å‡∏≤‡∏£‡∏Ñ‡πâ‡∏≤)
- Active Lots: ~3,000-5,000 lots (‡∏•‡πá‡∏≠‡∏ï‡∏ó‡∏µ‡πà‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô‡∏≠‡∏¢‡∏π‡πà)
- Vendors: ~100 companies (‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢)

---

## 4. Problems and Requirements | ‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡πÅ‡∏•‡∏∞‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£

### 4.1 Problem Statements | ‡∏Å‡∏≤‡∏£‡∏£‡∏∞‡∏ö‡∏∏‡∏õ‡∏±‡∏ç‡∏´‡∏≤

#### Problem 1: Lack of Real-time Budget Control

**‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏ó‡∏µ‡πà 1: ‡∏Ç‡∏≤‡∏î‡∏Å‡∏≤‡∏£‡∏Ñ‡∏ß‡∏ö‡∏Ñ‡∏∏‡∏°‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡πÅ‡∏ö‡∏ö‡∏ó‡∏±‡∏ô‡∏ó‡∏µ**

**Current Situation | ‡∏™‡∏ñ‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡∏ì‡πå‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô:**

- Budget checking is done manually before each purchase
- ‡∏Å‡∏≤‡∏£‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏ó‡∏≥‡∏î‡πâ‡∏ß‡∏¢‡∏°‡∏∑‡∏≠‡∏Å‡πà‡∏≠‡∏ô‡∏Å‡∏≤‡∏£‡∏ã‡∏∑‡πâ‡∏≠‡πÅ‡∏ï‡πà‡∏•‡∏∞‡∏Ñ‡∏£‡∏±‡πâ‡∏á
- No automated reservation system
- ‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏£‡∏∞‡∏ö‡∏ö‡∏à‡∏≠‡∏á‡∏á‡∏ö‡∏≠‡∏±‡∏ï‡πÇ‡∏ô‡∏°‡∏±‡∏ï‡∏¥
- Budget overruns discovered too late
- ‡∏û‡∏ö‡∏ß‡πà‡∏≤‡πÉ‡∏ä‡πâ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡πÄ‡∏Å‡∏¥‡∏ô‡πÄ‡∏°‡∏∑‡πà‡∏≠‡∏™‡∏≤‡∏¢‡πÄ‡∏Å‡∏¥‡∏ô‡πÑ‡∏õ

**Impact | ‡∏ú‡∏•‡∏Å‡∏£‡∏∞‡∏ó‡∏ö:**

- üí∞ 15-20% budget overruns per year
- üí∞ ‡πÉ‡∏ä‡πâ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡πÄ‡∏Å‡∏¥‡∏ô 15-20% ‡∏ï‡πà‡∏≠‡∏õ‡∏µ
- ‚è∞ 2-3 hours daily spent on manual checking
- ‚è∞ ‡πÉ‡∏ä‡πâ‡πÄ‡∏ß‡∏•‡∏≤‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡∏î‡πâ‡∏ß‡∏¢‡∏°‡∏∑‡∏≠ 2-3 ‡∏ä‡∏±‡πà‡∏ß‡πÇ‡∏°‡∏á‡∏ï‡πà‡∏≠‡∏ß‡∏±‡∏ô
- üìâ Poor budget utilization (unused allocations)
- üìâ ‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏õ‡∏£‡∏∞‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡∏†‡∏≤‡∏û (‡∏á‡∏ö‡∏ó‡∏µ‡πà‡πÑ‡∏°‡πà‡πÑ‡∏î‡πâ‡πÉ‡∏ä‡πâ)

**Required Solution | ‡πÇ‡∏ã‡∏•‡∏π‡∏ä‡∏±‡∏ô‡∏ó‡∏µ‡πà‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£:**

- ‚úÖ Real-time budget availability checking
- ‚úÖ ‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏Ñ‡∏á‡πÄ‡∏´‡∏•‡∏∑‡∏≠‡πÅ‡∏ö‡∏ö‡∏ó‡∏±‡∏ô‡∏ó‡∏µ
- ‚úÖ Automatic budget reservation for pending PRs
- ‚úÖ ‡∏à‡∏≠‡∏á‡∏á‡∏ö‡∏≠‡∏±‡∏ï‡πÇ‡∏ô‡∏°‡∏±‡∏ï‡∏¥‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠‡∏ó‡∏µ‡πà‡∏£‡∏≠‡∏Å‡∏≤‡∏£‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥
- ‚úÖ Quarterly budget monitoring dashboard
- ‚úÖ ‡πÅ‡∏î‡∏ä‡∏ö‡∏≠‡∏£‡πå‡∏î‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏£‡∏≤‡∏¢‡πÑ‡∏ï‡∏£‡∏°‡∏≤‡∏™

#### Problem 2: Incomplete Lot Tracking and Expiry Management

**‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏ó‡∏µ‡πà 2: ‡∏Å‡∏≤‡∏£‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏•‡πá‡∏≠‡∏ï‡πÅ‡∏•‡∏∞‡∏ß‡∏±‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡πÑ‡∏°‡πà‡∏™‡∏°‡∏ö‡∏π‡∏£‡∏ì‡πå**

**Current Situation | ‡∏™‡∏ñ‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡∏ì‡πå‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô:**

- Lot numbers recorded but not enforced in dispensing
- ‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡∏ö‡∏±‡∏ô‡∏ó‡∏∂‡∏Å‡∏´‡∏°‡∏≤‡∏¢‡πÄ‡∏•‡∏Ç‡∏•‡πá‡∏≠‡∏ï ‡πÅ‡∏ï‡πà‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡∏ö‡∏±‡∏á‡∏Ñ‡∏±‡∏ö‡πÉ‡∏ä‡πâ‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤
- No automated FIFO/FEFO logic
- ‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏£‡∏∞‡∏ö‡∏ö FIFO/FEFO ‡∏≠‡∏±‡∏ï‡πÇ‡∏ô‡∏°‡∏±‡∏ï‡∏¥
- Expiry alerts are manual and often missed
- ‡∏Å‡∏≤‡∏£‡πÅ‡∏à‡πâ‡∏á‡πÄ‡∏ï‡∏∑‡∏≠‡∏ô‡∏ß‡∏±‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏ó‡∏≥‡∏î‡πâ‡∏ß‡∏¢‡∏°‡∏∑‡∏≠‡πÅ‡∏•‡∏∞‡∏°‡∏±‡∏Å‡∏û‡∏•‡∏≤‡∏î

**Impact | ‡∏ú‡∏•‡∏Å‡∏£‡∏∞‡∏ó‡∏ö:**

- üíä 5-8% of drugs expire before use
- üíä ‡∏¢‡∏≤‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏Å‡πà‡∏≠‡∏ô‡∏ô‡∏≥‡πÑ‡∏õ‡πÉ‡∏ä‡πâ 5-8%
- üí∏ Estimated waste value: 500,000-1,000,000 THB/year
- üí∏ ‡∏°‡∏π‡∏•‡∏Ñ‡πà‡∏≤‡∏Å‡∏≤‡∏£‡∏™‡∏π‡∏ç‡πÄ‡∏™‡∏µ‡∏¢‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì: 500,000-1,000,000 ‡∏ö‡∏≤‡∏ó/‡∏õ‡∏µ
- ‚ö†Ô∏è Risk of dispensing expired drugs
- ‚ö†Ô∏è ‡∏°‡∏µ‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏

**Required Solution | ‡πÇ‡∏ã‡∏•‡∏π‡∏ä‡∏±‡∏ô‡∏ó‡∏µ‡πà‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£:**

- ‚úÖ Mandatory lot selection with FIFO/FEFO logic
- ‚úÖ ‡∏Å‡∏≤‡∏£‡πÄ‡∏•‡∏∑‡∏≠‡∏Å‡∏•‡πá‡∏≠‡∏ï‡πÅ‡∏ö‡∏ö‡∏ö‡∏±‡∏á‡∏Ñ‡∏±‡∏ö‡∏û‡∏£‡πâ‡∏≠‡∏°‡∏ï‡∏£‡∏£‡∏Å‡∏∞ FIFO/FEFO
- ‚úÖ Automated expiry alerts (90/60/30 days before expiry)
- ‚úÖ ‡πÅ‡∏à‡πâ‡∏á‡πÄ‡∏ï‡∏∑‡∏≠‡∏ô‡∏ß‡∏±‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏≠‡∏±‡∏ï‡πÇ‡∏ô‡∏°‡∏±‡∏ï‡∏¥ (90/60/30 ‡∏ß‡∏±‡∏ô‡∏Å‡πà‡∏≠‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏)
- ‚úÖ Blocked dispensing for expired drugs
- ‚úÖ ‡∏õ‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ô‡∏Å‡∏≤‡∏£‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤‡∏ó‡∏µ‡πà‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏

#### Problem 3: No Contract Management System

**‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏ó‡∏µ‡πà 3: ‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏£‡∏∞‡∏ö‡∏ö‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏±‡∏ç‡∏ç‡∏≤**

**Current Situation | ‡∏™‡∏ñ‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡∏ì‡πå‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô:**

- Contracts managed in separate files (Excel/Paper)
- ‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏±‡∏ç‡∏ç‡∏≤‡πÉ‡∏ô‡πÑ‡∏ü‡∏•‡πå‡πÅ‡∏¢‡∏Å (Excel/‡∏Å‡∏£‡∏∞‡∏î‡∏≤‡∏©)
- No integration with purchase orders
- ‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡πÇ‡∏¢‡∏á‡∏Å‡∏±‡∏ö‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠
- Cannot track contract spending vs. limit
- ‡πÑ‡∏°‡πà‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏à‡πà‡∏≤‡∏¢‡∏ï‡∏≤‡∏°‡∏™‡∏±‡∏ç‡∏ç‡∏≤‡πÑ‡∏î‡πâ

**Impact | ‡∏ú‡∏•‡∏Å‡∏£‡∏∞‡∏ó‡∏ö:**

- üìÑ Contract compliance issues
- üìÑ ‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏Å‡∏≤‡∏£‡∏õ‡∏è‡∏¥‡∏ö‡∏±‡∏ï‡∏¥‡∏ï‡∏≤‡∏°‡πÄ‡∏á‡∏∑‡πà‡∏≠‡∏ô‡πÑ‡∏Ç‡∏™‡∏±‡∏ç‡∏ç‡∏≤
- üí∞ Risk of exceeding contract limits
- üí∞ ‡∏°‡∏µ‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡πÉ‡∏ä‡πâ‡πÄ‡∏á‡∏¥‡∏ô‡πÄ‡∏Å‡∏¥‡∏ô‡∏ß‡∏á‡πÄ‡∏á‡∏¥‡∏ô‡∏™‡∏±‡∏ç‡∏ç‡∏≤
- ‚è∞ Delayed procurement due to contract verification
- ‚è∞ ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠‡∏•‡πà‡∏≤‡∏ä‡πâ‡∏≤‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏ï‡πâ‡∏≠‡∏á‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡∏™‡∏±‡∏ç‡∏ç‡∏≤

**Required Solution | ‡πÇ‡∏ã‡∏•‡∏π‡∏ä‡∏±‡∏ô‡∏ó‡∏µ‡πà‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£:**

- ‚úÖ Integrated contract management module
- ‚úÖ ‡πÇ‡∏°‡∏î‡∏π‡∏•‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏±‡∏ç‡∏ç‡∏≤‡πÅ‡∏ö‡∏ö‡∏ö‡∏π‡∏£‡∏ì‡∏≤‡∏Å‡∏≤‡∏£
- ‚úÖ Automatic contract selection in PR/PO
- ‚úÖ ‡πÄ‡∏•‡∏∑‡∏≠‡∏Å‡∏™‡∏±‡∏ç‡∏ç‡∏≤‡∏≠‡∏±‡∏ï‡πÇ‡∏ô‡∏°‡∏±‡∏ï‡∏¥‡πÉ‡∏ô‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠/‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠
- ‚úÖ Contract spending tracking and alerts
- ‚úÖ ‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏ß‡∏á‡πÄ‡∏á‡∏¥‡∏ô‡∏™‡∏±‡∏ç‡∏ç‡∏≤‡πÅ‡∏•‡∏∞‡πÅ‡∏à‡πâ‡∏á‡πÄ‡∏ï‡∏∑‡∏≠‡∏ô

#### Problem 4: Manual Ministry Reporting

**‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏ó‡∏µ‡πà 4: ‡∏Å‡∏≤‡∏£‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡πÉ‡∏´‡πâ‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏ó‡∏≥‡∏î‡πâ‡∏ß‡∏¢‡∏°‡∏∑‡∏≠**

**Current Situation | ‡∏™‡∏ñ‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡∏ì‡πå‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô:**

- 5 ministry files prepared manually each month
- ‡∏à‡∏±‡∏î‡∏ó‡∏≥‡πÑ‡∏ü‡∏•‡πå‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡πÉ‡∏´‡πâ‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á 5 ‡πÑ‡∏ü‡∏•‡πå‡∏î‡πâ‡∏ß‡∏¢‡∏°‡∏∑‡∏≠‡∏ó‡∏∏‡∏Å‡πÄ‡∏î‡∏∑‡∏≠‡∏ô
- Data exported from multiple sources and combined
- ‡∏î‡∏∂‡∏á‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏à‡∏≤‡∏Å‡∏´‡∏•‡∏≤‡∏¢‡πÅ‡∏´‡∏•‡πà‡∏á‡πÅ‡∏•‡πâ‡∏ß‡∏ô‡∏≥‡∏°‡∏≤‡∏£‡∏ß‡∏°‡∏Å‡∏±‡∏ô
- High error rate due to manual processes
- ‡∏≠‡∏±‡∏ï‡∏£‡∏≤‡∏Ç‡πâ‡∏≠‡∏ú‡∏¥‡∏î‡∏û‡∏•‡∏≤‡∏î‡∏™‡∏π‡∏á‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏Å‡∏£‡∏∞‡∏ö‡∏ß‡∏ô‡∏Å‡∏≤‡∏£‡∏ó‡∏≥‡∏î‡πâ‡∏ß‡∏¢‡∏°‡∏∑‡∏≠

**Impact | ‡∏ú‡∏•‡∏Å‡∏£‡∏∞‡∏ó‡∏ö:**

- ‚è∞ 8-10 hours per month spent on reporting
- ‚è∞ ‡πÉ‡∏ä‡πâ‡πÄ‡∏ß‡∏•‡∏≤ 8-10 ‡∏ä‡∏±‡πà‡∏ß‡πÇ‡∏°‡∏á‡∏ï‡πà‡∏≠‡πÄ‡∏î‡∏∑‡∏≠‡∏ô‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏ó‡∏≥‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô
- ‚ùå 15-20% error rate requiring corrections
- ‚ùå ‡∏≠‡∏±‡∏ï‡∏£‡∏≤‡∏Ç‡πâ‡∏≠‡∏ú‡∏¥‡∏î‡∏û‡∏•‡∏≤‡∏î 15-20% ‡∏ï‡πâ‡∏≠‡∏á‡πÅ‡∏Å‡πâ‡πÑ‡∏Ç
- üìÖ Late submissions due to complexity
- üìÖ ‡∏™‡πà‡∏á‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡∏•‡πà‡∏≤‡∏ä‡πâ‡∏≤‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ã‡∏±‡∏ö‡∏ã‡πâ‡∏≠‡∏ô

**Required Solution | ‡πÇ‡∏ã‡∏•‡∏π‡∏ä‡∏±‡∏ô‡∏ó‡∏µ‡πà‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£:**

- ‚úÖ Automated export of 5 ministry files
- ‚úÖ ‡∏™‡πà‡∏á‡∏≠‡∏≠‡∏Å‡πÑ‡∏ü‡∏•‡πå‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô 5 ‡πÑ‡∏ü‡∏•‡πå‡∏≠‡∏±‡∏ï‡πÇ‡∏ô‡∏°‡∏±‡∏ï‡∏¥
- ‚úÖ 100% compliance with DMSIC Standards ‡∏û.‡∏®. 2568
- ‚úÖ ‡∏™‡∏≠‡∏î‡∏Ñ‡∏•‡πâ‡∏≠‡∏á‡∏ï‡∏≤‡∏°‡∏°‡∏≤‡∏ï‡∏£‡∏ê‡∏≤‡∏ô DMSIC ‡∏û.‡∏®. 2568 ‡∏Ñ‡∏£‡∏ö 100%
- ‚úÖ One-click export with data validation
- ‚úÖ ‡∏™‡πà‡∏á‡∏≠‡∏≠‡∏Å‡∏Ñ‡∏•‡∏¥‡∏Å‡πÄ‡∏î‡∏µ‡∏¢‡∏ß‡∏û‡∏£‡πâ‡∏≠‡∏°‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ñ‡∏π‡∏Å‡∏ï‡πâ‡∏≠‡∏á‡∏Ç‡∏≠‡∏á‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•

#### Problem 5: Limited Reporting and Analytics

**‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏ó‡∏µ‡πà 5: ‡∏Å‡∏≤‡∏£‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏ß‡∏¥‡πÄ‡∏Ñ‡∏£‡∏≤‡∏∞‡∏´‡πå‡∏°‡∏µ‡∏Ç‡πâ‡∏≠‡∏à‡∏≥‡∏Å‡∏±‡∏î**

**Current Situation | ‡∏™‡∏ñ‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡∏ì‡πå‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô:**

- Basic reports only (stock levels, transactions)
- ‡∏°‡∏µ‡πÄ‡∏û‡∏µ‡∏¢‡∏á‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡∏û‡∏∑‡πâ‡∏ô‡∏ê‡∏≤‡∏ô (‡∏£‡∏∞‡∏î‡∏±‡∏ö‡∏™‡∏ï‡πá‡∏≠‡∏Å, ‡∏ò‡∏∏‡∏£‡∏Å‡∏£‡∏£‡∏°)
- No drug usage pattern analysis
- ‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡∏ß‡∏¥‡πÄ‡∏Ñ‡∏£‡∏≤‡∏∞‡∏´‡πå‡∏£‡∏π‡∏õ‡πÅ‡∏ö‡∏ö‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏¢‡∏≤
- Cannot identify slow-moving or fast-moving items
- ‡πÑ‡∏°‡πà‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏£‡∏∞‡∏ö‡∏∏‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤‡∏ó‡∏µ‡πà‡∏´‡∏°‡∏∏‡∏ô‡πÄ‡∏ß‡∏µ‡∏¢‡∏ô‡∏ä‡πâ‡∏≤‡∏´‡∏£‡∏∑‡∏≠‡πÄ‡∏£‡πá‡∏ß‡πÑ‡∏î‡πâ

**Impact | ‡∏ú‡∏•‡∏Å‡∏£‡∏∞‡∏ó‡∏ö:**

- üìä Poor demand forecasting
- üìä ‡∏Å‡∏≤‡∏£‡∏Ñ‡∏≤‡∏î‡∏Å‡∏≤‡∏£‡∏ì‡πå‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏õ‡∏£‡∏∞‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡∏†‡∏≤‡∏û
- üí∞ Overstocking slow-moving items
- üí∞ ‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤‡∏´‡∏°‡∏∏‡∏ô‡πÄ‡∏ß‡∏µ‡∏¢‡∏ô‡∏ä‡πâ‡∏≤‡∏™‡∏π‡∏á‡πÄ‡∏Å‡∏¥‡∏ô‡πÑ‡∏õ
- üìâ Stockouts of fast-moving items
- üìâ ‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤‡∏´‡∏°‡∏∏‡∏ô‡πÄ‡∏ß‡∏µ‡∏¢‡∏ô‡πÄ‡∏£‡πá‡∏ß‡∏´‡∏°‡∏î

**Required Solution | ‡πÇ‡∏ã‡∏•‡∏π‡∏ä‡∏±‡∏ô‡∏ó‡∏µ‡πà‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£:**

- ‚úÖ ABC-VEN analysis for drug classification
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏ß‡∏¥‡πÄ‡∏Ñ‡∏£‡∏≤‡∏∞‡∏´‡πå ABC-VEN ‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏à‡∏±‡∏î‡∏Å‡∏•‡∏∏‡πà‡∏°‡∏¢‡∏≤
- ‚úÖ Usage pattern reports with trends
- ‚úÖ ‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡∏£‡∏π‡∏õ‡πÅ‡∏ö‡∏ö‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏û‡∏£‡πâ‡∏≠‡∏°‡πÅ‡∏ô‡∏ß‡πÇ‡∏ô‡πâ‡∏°
- ‚úÖ Interactive dashboards for decision-making
- ‚úÖ ‡πÅ‡∏î‡∏ä‡∏ö‡∏≠‡∏£‡πå‡∏î‡πÅ‡∏ö‡∏ö‡πÇ‡∏ï‡πâ‡∏ï‡∏≠‡∏ö‡πÑ‡∏î‡πâ‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏Å‡∏≤‡∏£‡∏ï‡∏±‡∏î‡∏™‡∏¥‡∏ô‡πÉ‡∏à

### 4.2 Requirements Summary | ‡∏™‡∏£‡∏∏‡∏õ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£

**Must Have (Critical) | ‡∏ï‡πâ‡∏≠‡∏á‡∏°‡∏µ (‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏°‡∏≤‡∏Å):**

1. ‚úÖ Real-time budget checking and control
2. ‚úÖ FIFO/FEFO lot tracking
3. ‚úÖ 100% Ministry compliance (5 export files)
4. ‚úÖ Multi-location inventory management
5. ‚úÖ Purchase request approval workflow

**Should Have (Important) | ‡∏Ñ‡∏ß‡∏£‡∏°‡∏µ (‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç):**

1. ‚≠ê Contract management integration
2. ‚≠ê ABC-VEN analysis
3. ‚≠ê Mobile responsive interface
4. ‚≠ê Expiry alert system
5. ‚≠ê Vendor performance tracking

**Could Have (Nice to Have) | ‡∏≠‡∏≤‡∏à‡∏°‡∏µ (‡∏î‡∏µ‡∏ñ‡πâ‡∏≤‡∏°‡∏µ):**

1. üí° AI-powered demand forecasting
2. üí° Barcode scanning integration
3. üí° Automated reorder suggestions
4. üí° SMS notifications
5. üí° Multi-language support

---

## 5. Project Scope | ‡∏Ç‡∏≠‡∏ö‡πÄ‡∏Ç‡∏ï‡πÇ‡∏Ñ‡∏£‡∏á‡∏Å‡∏≤‡∏£

### 5.1 In Scope | ‡∏≠‡∏¢‡∏π‡πà‡πÉ‡∏ô‡∏Ç‡∏≠‡∏ö‡πÄ‡∏Ç‡∏ï

**System Components | ‡∏≠‡∏á‡∏Ñ‡πå‡∏õ‡∏£‡∏∞‡∏Å‡∏≠‡∏ö‡∏Ç‡∏≠‡∏á‡∏£‡∏∞‡∏ö‡∏ö:**

#### 1. Master Data Management | ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏´‡∏•‡∏±‡∏Å

- ‚úÖ Drug catalog (Generic + Trade drugs)
- ‚úÖ ‡∏£‡∏≤‡∏¢‡∏Å‡∏≤‡∏£‡∏¢‡∏≤ (‡∏¢‡∏≤‡∏ä‡∏∑‡πà‡∏≠‡∏™‡∏≤‡∏°‡∏±‡∏ç + ‡∏¢‡∏≤‡∏ä‡∏∑‡πà‡∏≠‡∏Å‡∏≤‡∏£‡∏Ñ‡πâ‡∏≤)
- ‚úÖ Vendor/Company management
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢/‡∏ö‡∏£‡∏¥‡∏©‡∏±‡∏ó
- ‚úÖ Location and department setup
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏ï‡∏±‡πâ‡∏á‡∏Ñ‡πà‡∏≤‡∏™‡∏ñ‡∏≤‡∏ô‡∏ó‡∏µ‡πà‡πÅ‡∏•‡∏∞‡πÅ‡∏ú‡∏ô‡∏Å
- ‚úÖ Budget type configuration
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡∏Ñ‡πà‡∏≤‡∏õ‡∏£‡∏∞‡πÄ‡∏†‡∏ó‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì

#### 2. Budget Management | ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì

- ‚úÖ Annual budget allocation
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏™‡∏£‡∏£‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏£‡∏≤‡∏¢‡∏õ‡∏µ
- ‚úÖ Quarterly budget breakdown (Q1-Q4)
- ‚úÖ ‡∏Å‡∏≤‡∏£‡πÅ‡∏ö‡πà‡∏á‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏£‡∏≤‡∏¢‡πÑ‡∏ï‡∏£‡∏°‡∏≤‡∏™ (Q1-Q4)
- ‚úÖ Budget reservation system
- ‚úÖ ‡∏£‡∏∞‡∏ö‡∏ö‡∏à‡∏≠‡∏á‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì
- ‚úÖ Real-time availability checking
- ‚úÖ ‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏Ñ‡∏á‡πÄ‡∏´‡∏•‡∏∑‡∏≠‡πÅ‡∏ö‡∏ö‡∏ó‡∏±‡∏ô‡∏ó‡∏µ
- ‚úÖ Budget monitoring and reporting
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡πÅ‡∏•‡∏∞‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì

#### 3. Procurement Management | ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠

- ‚úÖ Purchase request workflow
- ‚úÖ ‡∏Å‡∏£‡∏∞‡∏ö‡∏ß‡∏ô‡∏Å‡∏≤‡∏£‡∏Ç‡∏≠‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥‡∏ã‡∏∑‡πâ‡∏≠
- ‚úÖ Multi-level approval process
- ‚úÖ ‡∏Å‡∏£‡∏∞‡∏ö‡∏ß‡∏ô‡∏Å‡∏≤‡∏£‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥‡∏´‡∏•‡∏≤‡∏¢‡∏Ç‡∏±‡πâ‡∏ô‡∏ï‡∏≠‡∏ô
- ‚úÖ Purchase order generation
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏™‡∏£‡πâ‡∏≤‡∏á‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠
- ‚úÖ Goods receiving management
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏ö‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤
- ‚úÖ Invoice reconciliation
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡πÉ‡∏ö‡πÅ‡∏à‡πâ‡∏á‡∏´‡∏ô‡∏µ‡πâ

#### 4. Inventory Management | ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏ï‡πá‡∏≠‡∏Å

- ‚úÖ Multi-location stock tracking
- ‚úÖ ‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏™‡∏ï‡πá‡∏≠‡∏Å‡πÅ‡∏ö‡∏ö‡∏´‡∏•‡∏≤‡∏¢‡∏™‡∏ñ‡∏≤‡∏ô‡∏ó‡∏µ‡πà
- ‚úÖ FIFO/FEFO lot management
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏•‡πá‡∏≠‡∏ï‡πÅ‡∏ö‡∏ö FIFO/FEFO
- ‚úÖ Expiry date tracking
- ‚úÖ ‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏ß‡∏±‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏
- ‚úÖ Reorder point management
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏à‡∏∏‡∏î‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠‡∏ã‡πâ‡∏≥
- ‚úÖ Inventory adjustments and transfers
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏õ‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∏‡∏á‡πÅ‡∏•‡∏∞‡πÇ‡∏≠‡∏ô‡∏¢‡πâ‡∏≤‡∏¢‡∏™‡∏ï‡πá‡∏≠‡∏Å

#### 5. Distribution Management | ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢

- ‚úÖ Department requisition workflow
- ‚úÖ ‡∏Å‡∏£‡∏∞‡∏ö‡∏ß‡∏ô‡∏Å‡∏≤‡∏£‡∏Ç‡∏≠‡πÄ‡∏ö‡∏¥‡∏Å‡∏Ç‡∏≠‡∏á‡πÅ‡∏ú‡∏ô‡∏Å
- ‚úÖ FEFO-based lot selection
- ‚úÖ ‡∏Å‡∏≤‡∏£‡πÄ‡∏•‡∏∑‡∏≠‡∏Å‡∏•‡πá‡∏≠‡∏ï‡∏ï‡∏≤‡∏°‡∏´‡∏•‡∏±‡∏Å FEFO
- ‚úÖ Distribution tracking and reporting
- ‚úÖ ‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡πÅ‡∏•‡∏∞‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢

#### 6. Reporting and Analytics | ‡∏Å‡∏≤‡∏£‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏ß‡∏¥‡πÄ‡∏Ñ‡∏£‡∏≤‡∏∞‡∏´‡πå

- ‚úÖ Ministry export files (5 files)
- ‚úÖ ‡πÑ‡∏ü‡∏•‡πå‡∏™‡πà‡∏á‡∏≠‡∏≠‡∏Å‡πÉ‡∏´‡πâ‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á (5 ‡πÑ‡∏ü‡∏•‡πå)
  - DRUGLIST (‡∏£‡∏≤‡∏¢‡∏Å‡∏≤‡∏£‡∏¢‡∏≤)
  - PURCHASEPLAN (‡πÅ‡∏ú‡∏ô‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠)
  - RECEIPT (‡πÉ‡∏ö‡∏£‡∏±‡∏ö‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤)
  - DISTRIBUTION (‡πÉ‡∏ö‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤)
  - INVENTORY (‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏Ñ‡∏á‡πÄ‡∏´‡∏•‡∏∑‡∏≠)
- ‚úÖ Budget status reports
- ‚úÖ ‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡∏™‡∏ñ‡∏≤‡∏ô‡∏∞‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì
- ‚úÖ Stock level reports
- ‚úÖ ‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡∏£‡∏∞‡∏î‡∏±‡∏ö‡∏™‡∏ï‡πá‡∏≠‡∏Å
- ‚úÖ Expiring drugs alerts
- ‚úÖ ‡∏Å‡∏≤‡∏£‡πÅ‡∏à‡πâ‡∏á‡πÄ‡∏ï‡∏∑‡∏≠‡∏ô‡∏¢‡∏≤‡πÉ‡∏Å‡∏•‡πâ‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏
- ‚úÖ Usage pattern analysis
- ‚úÖ ‡∏Å‡∏≤‡∏£‡∏ß‡∏¥‡πÄ‡∏Ñ‡∏£‡∏≤‡∏∞‡∏´‡πå‡∏£‡∏π‡∏õ‡πÅ‡∏ö‡∏ö‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ

### 5.2 Out of Scope | ‡∏ô‡∏≠‡∏Å‡∏Ç‡∏≠‡∏ö‡πÄ‡∏Ç‡∏ï

**Not Included in Current Phase | ‡πÑ‡∏°‡πà‡∏£‡∏ß‡∏°‡∏≠‡∏¢‡∏π‡πà‡πÉ‡∏ô‡∏£‡∏∞‡∏¢‡∏∞‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô:**

- ‚ùå HIS (Hospital Information System) integration
- ‚ùå ‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡πÇ‡∏¢‡∏á‡∏Å‡∏±‡∏ö‡∏£‡∏∞‡∏ö‡∏ö‡∏™‡∏≤‡∏£‡∏™‡∏ô‡πÄ‡∏ó‡∏®‡πÇ‡∏£‡∏á‡∏û‡∏¢‡∏≤‡∏ö‡∏≤‡∏• (HIS)
- ‚ùå Electronic Health Records (EHR) integration
- ‚ùå ‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡πÇ‡∏¢‡∏á‡∏Å‡∏±‡∏ö‡∏£‡∏∞‡∏ö‡∏ö‡∏ö‡∏±‡∏ô‡∏ó‡∏∂‡∏Å‡∏™‡∏∏‡∏Ç‡∏†‡∏≤‡∏û‡∏≠‡∏¥‡πÄ‡∏•‡πá‡∏Å‡∏ó‡∏£‡∏≠‡∏ô‡∏¥‡∏Å‡∏™‡πå (EHR)
- ‚ùå Patient billing integration
- ‚ùå ‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡πÇ‡∏¢‡∏á‡∏Å‡∏±‡∏ö‡∏£‡∏∞‡∏ö‡∏ö‡πÄ‡∏£‡∏µ‡∏¢‡∏Å‡πÄ‡∏Å‡πá‡∏ö‡πÄ‡∏á‡∏¥‡∏ô‡∏ú‡∏π‡πâ‡∏õ‡πà‡∏ß‡∏¢
- ‚ùå Pharmacy dispensing at ward level
- ‚ùå ‡∏Å‡∏≤‡∏£‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤‡∏£‡∏∞‡∏î‡∏±‡∏ö‡∏´‡∏≠‡∏ú‡∏π‡πâ‡∏õ‡πà‡∏ß‡∏¢
- ‚ùå Clinical decision support
- ‚ùå ‡∏£‡∏∞‡∏ö‡∏ö‡∏™‡∏ô‡∏±‡∏ö‡∏™‡∏ô‡∏∏‡∏ô‡∏Å‡∏≤‡∏£‡∏ï‡∏±‡∏î‡∏™‡∏¥‡∏ô‡πÉ‡∏à‡∏ó‡∏≤‡∏á‡∏Ñ‡∏•‡∏¥‡∏ô‡∏¥‡∏Å
- ‚ùå E-procurement with vendor portals
- ‚ùå ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠‡∏≠‡∏¥‡πÄ‡∏•‡πá‡∏Å‡∏ó‡∏£‡∏≠‡∏ô‡∏¥‡∏Å‡∏™‡πå‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢

**Future Considerations | ‡∏û‡∏¥‡∏à‡∏≤‡∏£‡∏ì‡∏≤‡πÉ‡∏ô‡∏≠‡∏ô‡∏≤‡∏Ñ‡∏ï:**

- üîÆ AI-powered demand forecasting
- üîÆ ‡∏Å‡∏≤‡∏£‡∏Ñ‡∏≤‡∏î‡∏Å‡∏≤‡∏£‡∏ì‡πå‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡∏î‡πâ‡∏ß‡∏¢‡∏õ‡∏±‡∏ç‡∏ç‡∏≤‡∏õ‡∏£‡∏∞‡∏î‡∏¥‡∏©‡∏ê‡πå
- üîÆ Blockchain for supply chain tracking
- üîÆ ‡πÄ‡∏ó‡∏Ñ‡πÇ‡∏ô‡πÇ‡∏•‡∏¢‡∏µ‡∏ö‡∏•‡πá‡∏≠‡∏Å‡πÄ‡∏ä‡∏ô‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏´‡πà‡∏ß‡∏á‡πÇ‡∏ã‡πà‡∏≠‡∏∏‡∏õ‡∏ó‡∏≤‡∏ô
- üîÆ IoT sensors for automated stock counting
- üîÆ ‡πÄ‡∏ã‡πá‡∏ô‡πÄ‡∏ã‡∏≠‡∏£‡πå IoT ‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏ô‡∏±‡∏ö‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏≠‡∏±‡∏ï‡πÇ‡∏ô‡∏°‡∏±‡∏ï‡∏¥

---

## 7. Business Rules | ‡∏Å‡∏é‡∏ó‡∏≤‡∏á‡∏ò‡∏∏‡∏£‡∏Å‡∏¥‡∏à

### 7.1 Budget Rules | ‡∏Å‡∏é‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏Å‡∏±‡∏ö‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì

**BR-BUD-001: Budget Allocation**

- Budget must be allocated by fiscal year (October 1 - September 30)
- ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏ï‡πâ‡∏≠‡∏á‡∏à‡∏±‡∏î‡∏™‡∏£‡∏£‡∏ï‡∏≤‡∏°‡∏õ‡∏µ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì (1 ‡∏ï‡∏∏‡∏•‡∏≤‡∏Ñ‡∏° - 30 ‡∏Å‡∏±‡∏ô‡∏¢‡∏≤‡∏¢‡∏ô)
- Total quarterly allocation (Q1+Q2+Q3+Q4) must equal annual budget
- ‡∏ú‡∏•‡∏£‡∏ß‡∏°‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏ó‡∏±‡πâ‡∏á 4 ‡πÑ‡∏ï‡∏£‡∏°‡∏≤‡∏™ (Q1+Q2+Q3+Q4) ‡∏ï‡πâ‡∏≠‡∏á‡πÄ‡∏ó‡πà‡∏≤‡∏Å‡∏±‡∏ö‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏£‡∏≤‡∏¢‡∏õ‡∏µ

**BR-BUD-002: Budget Checking**

- All purchase requests must have sufficient budget before approval
- ‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠‡∏ó‡∏±‡πâ‡∏á‡∏´‡∏°‡∏î‡∏ï‡πâ‡∏≠‡∏á‡∏°‡∏µ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡πÄ‡∏û‡∏µ‡∏¢‡∏á‡∏û‡∏≠‡∏Å‡πà‡∏≠‡∏ô‡∏Å‡∏≤‡∏£‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥
- Budget check considers current quarter allocation
- ‡∏Å‡∏≤‡∏£‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏û‡∏¥‡∏à‡∏≤‡∏£‡∏ì‡∏≤‡∏à‡∏≤‡∏Å‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏™‡∏£‡∏£‡∏Ç‡∏≠‡∏á‡πÑ‡∏ï‡∏£‡∏°‡∏≤‡∏™‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô
- Reserved budget is excluded from available amount
- ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏ó‡∏µ‡πà‡∏à‡∏≠‡∏á‡πÑ‡∏ß‡πâ‡∏à‡∏∞‡πÑ‡∏°‡πà‡∏ô‡∏±‡∏ö‡∏£‡∏ß‡∏°‡πÉ‡∏ô‡∏à‡∏≥‡∏ô‡∏ß‡∏ô‡∏ó‡∏µ‡πà‡∏û‡∏£‡πâ‡∏≠‡∏°‡πÉ‡∏ä‡πâ

**BR-BUD-003: Budget Reservation**

- Budget is auto-reserved when PR is approved
- ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏ñ‡∏π‡∏Å‡∏à‡∏≠‡∏á‡πÇ‡∏î‡∏¢‡∏≠‡∏±‡∏ï‡πÇ‡∏ô‡∏°‡∏±‡∏ï‡∏¥‡πÄ‡∏°‡∏∑‡πà‡∏≠‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠‡πÑ‡∏î‡πâ‡∏£‡∏±‡∏ö‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥
- Reservation expires after 30 days if PO not created
- ‡∏Å‡∏≤‡∏£‡∏à‡∏≠‡∏á‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏´‡∏•‡∏±‡∏á 30 ‡∏ß‡∏±‡∏ô ‡∏´‡∏≤‡∏Å‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡∏™‡∏£‡πâ‡∏≤‡∏á‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠
- Expired reservations are auto-released
- ‡∏Å‡∏≤‡∏£‡∏à‡∏≠‡∏á‡∏ó‡∏µ‡πà‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏à‡∏∞‡∏ñ‡∏π‡∏Å‡∏õ‡∏•‡∏î‡∏•‡πá‡∏≠‡∏Å‡πÇ‡∏î‡∏¢‡∏≠‡∏±‡∏ï‡πÇ‡∏ô‡∏°‡∏±‡∏ï‡∏¥

**BR-BUD-004: Budget Commitment**

- Budget is committed when PO is finalized
- ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏ñ‡∏π‡∏Å‡∏¢‡∏∑‡∏ô‡∏¢‡∏±‡∏ô‡πÄ‡∏°‡∏∑‡πà‡∏≠‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠‡πÅ‡∏•‡πâ‡∏ß‡πÄ‡∏™‡∏£‡πá‡∏à
- Committed budget cannot be used for other purchases
- ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏ó‡∏µ‡πà‡∏¢‡∏∑‡∏ô‡∏¢‡∏±‡∏ô‡πÅ‡∏•‡πâ‡∏ß‡πÑ‡∏°‡πà‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡πÉ‡∏ä‡πâ‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏Å‡∏≤‡∏£‡∏ã‡∏∑‡πâ‡∏≠‡∏≠‡∏∑‡πà‡∏ô‡πÑ‡∏î‡πâ

### 7.2 Inventory Rules | ‡∏Å‡∏é‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏Å‡∏±‡∏ö‡∏™‡∏ï‡πá‡∏≠‡∏Å

**BR-INV-001: Lot Tracking**

- Every receipt must record lot number and expiry date
- ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏ö‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤‡∏ó‡∏∏‡∏Å‡∏Ñ‡∏£‡∏±‡πâ‡∏á‡∏ï‡πâ‡∏≠‡∏á‡∏ö‡∏±‡∏ô‡∏ó‡∏∂‡∏Å‡∏´‡∏°‡∏≤‡∏¢‡πÄ‡∏•‡∏Ç‡∏•‡πá‡∏≠‡∏ï‡πÅ‡∏•‡∏∞‡∏ß‡∏±‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏
- Lot number must be unique per drug per receipt
- ‡∏´‡∏°‡∏≤‡∏¢‡πÄ‡∏•‡∏Ç‡∏•‡πá‡∏≠‡∏ï‡∏ï‡πâ‡∏≠‡∏á‡πÑ‡∏°‡πà‡∏ã‡πâ‡∏≥‡∏Å‡∏±‡∏ô‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡πÅ‡∏ï‡πà‡∏•‡∏∞‡∏¢‡∏≤‡πÉ‡∏ô‡πÅ‡∏ï‡πà‡∏•‡∏∞‡∏Ñ‡∏£‡∏±‡πâ‡∏á‡∏ó‡∏µ‡πà‡∏£‡∏±‡∏ö

**BR-INV-002: FIFO/FEFO Rules**

- Drug distribution must follow FEFO logic (earliest expiry first)
- ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤‡∏ï‡πâ‡∏≠‡∏á‡∏ï‡∏≤‡∏°‡∏´‡∏•‡∏±‡∏Å FEFO (‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏Å‡πà‡∏≠‡∏ô‡∏à‡πà‡∏≤‡∏¢‡∏Å‡πà‡∏≠‡∏ô)
- System shall block selection of expired lots
- ‡∏£‡∏∞‡∏ö‡∏ö‡∏ï‡πâ‡∏≠‡∏á‡∏õ‡πâ‡∏≠‡∏á‡∏Å‡∏±‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏•‡∏∑‡∏≠‡∏Å‡∏•‡πá‡∏≠‡∏ï‡∏ó‡∏µ‡πà‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏
- FIFO applies if expiry dates are equal
- ‡πÉ‡∏ä‡πâ‡∏´‡∏•‡∏±‡∏Å FIFO ‡∏ñ‡πâ‡∏≤‡∏ß‡∏±‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡πÄ‡∏ó‡πà‡∏≤‡∏Å‡∏±‡∏ô

**BR-INV-003: Expiry Alerts**

- Alert 90 days before expiry for critical/expensive drugs (A/V category)
- ‡πÅ‡∏à‡πâ‡∏á‡πÄ‡∏ï‡∏∑‡∏≠‡∏ô 90 ‡∏ß‡∏±‡∏ô‡∏Å‡πà‡∏≠‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏¢‡∏≤‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç/‡πÅ‡∏û‡∏á (‡∏´‡∏°‡∏ß‡∏î A/V)
- Alert 60 days before expiry for medium importance drugs (B category)
- ‡πÅ‡∏à‡πâ‡∏á‡πÄ‡∏ï‡∏∑‡∏≠‡∏ô 60 ‡∏ß‡∏±‡∏ô‡∏Å‡πà‡∏≠‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏¢‡∏≤‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏õ‡∏≤‡∏ô‡∏Å‡∏•‡∏≤‡∏á (‡∏´‡∏°‡∏ß‡∏î B)
- Alert 30 days before expiry for all drugs
- ‡πÅ‡∏à‡πâ‡∏á‡πÄ‡∏ï‡∏∑‡∏≠‡∏ô 30 ‡∏ß‡∏±‡∏ô‡∏Å‡πà‡∏≠‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏¢‡∏≤‡∏ó‡∏∏‡∏Å‡∏£‡∏≤‡∏¢‡∏Å‡∏≤‡∏£

**BR-INV-004: Stock Levels**

- Minimum stock level must be less than maximum stock level
- ‡∏£‡∏∞‡∏î‡∏±‡∏ö‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏Ç‡∏±‡πâ‡∏ô‡∏ï‡πà‡∏≥‡∏ï‡πâ‡∏≠‡∏á‡∏ô‡πâ‡∏≠‡∏¢‡∏Å‡∏ß‡πà‡∏≤‡∏£‡∏∞‡∏î‡∏±‡∏ö‡∏™‡∏π‡∏á‡∏™‡∏∏‡∏î
- Reorder point should be between minimum and maximum
- ‡∏à‡∏∏‡∏î‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠‡∏ã‡πâ‡∏≥‡∏Ñ‡∏ß‡∏£‡∏≠‡∏¢‡∏π‡πà‡∏£‡∏∞‡∏´‡∏ß‡πà‡∏≤‡∏á‡∏Ç‡∏±‡πâ‡∏ô‡∏ï‡πà‡∏≥‡πÅ‡∏•‡∏∞‡∏™‡∏π‡∏á‡∏™‡∏∏‡∏î
- Low stock alert triggers when stock falls below reorder point
- ‡∏Å‡∏≤‡∏£‡πÅ‡∏à‡πâ‡∏á‡πÄ‡∏ï‡∏∑‡∏≠‡∏ô‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏ï‡πà‡∏≥‡∏à‡∏∞‡∏ó‡∏≥‡∏á‡∏≤‡∏ô‡πÄ‡∏°‡∏∑‡πà‡∏≠‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏•‡∏î‡∏ï‡πà‡∏≥‡∏Å‡∏ß‡πà‡∏≤‡∏à‡∏∏‡∏î‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠‡∏ã‡πâ‡∏≥

**BR-INV-005: Inventory Transactions**

- All inventory changes must be recorded with transaction type
- ‡∏Å‡∏≤‡∏£‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡πÅ‡∏õ‡∏•‡∏á‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏ó‡∏±‡πâ‡∏á‡∏´‡∏°‡∏î‡∏ï‡πâ‡∏≠‡∏á‡∏ö‡∏±‡∏ô‡∏ó‡∏∂‡∏Å‡∏û‡∏£‡πâ‡∏≠‡∏°‡∏õ‡∏£‡∏∞‡πÄ‡∏†‡∏ó‡∏ò‡∏∏‡∏£‡∏Å‡∏£‡∏£‡∏°
- Transaction types: RECEIVE, ISSUE, TRANSFER, ADJUST, RETURN
- ‡∏õ‡∏£‡∏∞‡πÄ‡∏†‡∏ó‡∏ò‡∏∏‡∏£‡∏Å‡∏£‡∏£‡∏°: ‡∏£‡∏±‡∏ö, ‡∏à‡πà‡∏≤‡∏¢, ‡πÇ‡∏≠‡∏ô‡∏¢‡πâ‡∏≤‡∏¢, ‡∏õ‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∏‡∏á, ‡∏Ñ‡∏∑‡∏ô
- Negative stock balance is not allowed
- ‡πÑ‡∏°‡πà‡∏≠‡∏ô‡∏∏‡∏ç‡∏≤‡∏ï‡πÉ‡∏´‡πâ‡∏°‡∏µ‡∏¢‡∏≠‡∏î‡∏Ñ‡∏á‡πÄ‡∏´‡∏•‡∏∑‡∏≠‡∏ï‡∏¥‡∏î‡∏•‡∏ö

### 7.3 Procurement Rules | ‡∏Å‡∏é‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏Å‡∏±‡∏ö‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠

**BR-PROC-001: Purchase Request Approval**

- PR amount < 10,000 THB: Department head approval
- ‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠ < 10,000 ‡∏ö‡∏≤‡∏ó: ‡∏´‡∏±‡∏ß‡∏´‡∏ô‡πâ‡∏≤‡πÅ‡∏ú‡∏ô‡∏Å‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥
- PR amount 10,000-100,000 THB: Pharmacy manager + Finance approval
- ‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠ 10,000-100,000 ‡∏ö‡∏≤‡∏ó: ‡∏´‡∏±‡∏ß‡∏´‡∏ô‡πâ‡∏≤‡πÄ‡∏†‡∏™‡∏±‡∏ä‡∏Å‡∏£‡∏£‡∏° + ‡∏Å‡∏≤‡∏£‡πÄ‡∏á‡∏¥‡∏ô‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥
- PR amount > 100,000 THB: Pharmacy manager + Finance + Director approval
- ‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠ > 100,000 ‡∏ö‡∏≤‡∏ó: ‡∏´‡∏±‡∏ß‡∏´‡∏ô‡πâ‡∏≤‡πÄ‡∏†‡∏™‡∏±‡∏ä‡∏Å‡∏£‡∏£‡∏° + ‡∏Å‡∏≤‡∏£‡πÄ‡∏á‡∏¥‡∏ô + ‡∏ú‡∏π‡πâ‡∏≠‡∏≥‡∏ô‡∏ß‡∏¢‡∏Å‡∏≤‡∏£‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥

**BR-PROC-002: Purchase Order**

- PO can only be created from approved PR
- ‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏™‡∏£‡πâ‡∏≤‡∏á‡πÑ‡∏î‡πâ‡∏à‡∏≤‡∏Å‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠‡∏ó‡∏µ‡πà‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥‡πÅ‡∏•‡πâ‡∏ß‡πÄ‡∏ó‡πà‡∏≤‡∏ô‡∏±‡πâ‡∏ô
- PO amount cannot exceed PR approved amount
- ‡∏à‡∏≥‡∏ô‡∏ß‡∏ô‡πÄ‡∏á‡∏¥‡∏ô‡πÉ‡∏ô‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠‡∏ï‡πâ‡∏≠‡∏á‡πÑ‡∏°‡πà‡πÄ‡∏Å‡∏¥‡∏ô‡∏à‡∏≥‡∏ô‡∏ß‡∏ô‡∏ó‡∏µ‡πà‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥‡πÉ‡∏ô‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠
- PO must have valid vendor
- ‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠‡∏ï‡πâ‡∏≠‡∏á‡∏£‡∏∞‡∏ö‡∏∏‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢‡∏ó‡∏µ‡πà‡∏ñ‡∏π‡∏Å‡∏ï‡πâ‡∏≠‡∏á

**BR-PROC-003: Goods Receiving**

- Goods can only be received against valid PO
- ‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏£‡∏±‡∏ö‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤‡πÑ‡∏î‡πâ‡∏à‡∏≤‡∏Å‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠‡∏ó‡∏µ‡πà‡∏ñ‡∏π‡∏Å‡∏ï‡πâ‡∏≠‡∏á‡πÄ‡∏ó‡πà‡∏≤‡∏ô‡∏±‡πâ‡∏ô
- Received quantity cannot exceed PO quantity
- ‡∏õ‡∏£‡∏¥‡∏°‡∏≤‡∏ì‡∏ó‡∏µ‡πà‡∏£‡∏±‡∏ö‡∏ï‡πâ‡∏≠‡∏á‡πÑ‡∏°‡πà‡πÄ‡∏Å‡∏¥‡∏ô‡∏õ‡∏£‡∏¥‡∏°‡∏≤‡∏ì‡πÉ‡∏ô‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠
- Partial receiving is allowed
- ‡∏≠‡∏ô‡∏∏‡∏ç‡∏≤‡∏ï‡πÉ‡∏´‡πâ‡∏£‡∏±‡∏ö‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤‡πÄ‡∏õ‡πá‡∏ô‡∏ö‡∏≤‡∏á‡∏™‡πà‡∏ß‡∏ô‡πÑ‡∏î‡πâ

### 7.4 Distribution Rules | ‡∏Å‡∏é‡πÄ‡∏Å‡∏µ‡πà‡∏¢‡∏ß‡∏Å‡∏±‡∏ö‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢

**BR-DIST-001: Distribution Request**

- Only authorized departments can request distribution
- ‡πÄ‡∏â‡∏û‡∏≤‡∏∞‡πÅ‡∏ú‡∏ô‡∏Å‡∏ó‡∏µ‡πà‡πÑ‡∏î‡πâ‡∏£‡∏±‡∏ö‡∏≠‡∏ô‡∏∏‡∏ç‡∏≤‡∏ï‡πÄ‡∏ó‡πà‡∏≤‡∏ô‡∏±‡πâ‡∏ô‡∏ó‡∏µ‡πà‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏Ç‡∏≠‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢‡πÑ‡∏î‡πâ
- Distribution request must specify required quantity
- ‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢‡∏ï‡πâ‡∏≠‡∏á‡∏£‡∏∞‡∏ö‡∏∏‡∏õ‡∏£‡∏¥‡∏°‡∏≤‡∏ì‡∏ó‡∏µ‡πà‡∏ï‡πâ‡∏≠‡∏á‡∏Å‡∏≤‡∏£

**BR-DIST-002: Distribution Fulfillment**

- Distribution must use FEFO lot selection
- ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢‡∏ï‡πâ‡∏≠‡∏á‡πÉ‡∏ä‡πâ‡∏Å‡∏≤‡∏£‡πÄ‡∏•‡∏∑‡∏≠‡∏Å‡∏•‡πá‡∏≠‡∏ï‡∏ï‡∏≤‡∏°‡∏´‡∏•‡∏±‡∏Å FEFO
- Cannot distribute from expired lots
- ‡πÑ‡∏°‡πà‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢‡∏à‡∏≤‡∏Å‡∏•‡πá‡∏≠‡∏ï‡∏ó‡∏µ‡πà‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡πÑ‡∏î‡πâ
- Source location must have sufficient stock
- ‡∏™‡∏ñ‡∏≤‡∏ô‡∏ó‡∏µ‡πà‡∏ï‡πâ‡∏ô‡∏ó‡∏≤‡∏á‡∏ï‡πâ‡∏≠‡∏á‡∏°‡∏µ‡∏™‡∏ï‡πá‡∏≠‡∏Å‡πÄ‡∏û‡∏µ‡∏¢‡∏á‡∏û‡∏≠

---

## 8. Compliance Requirements | ‡∏Ç‡πâ‡∏≠‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡∏î‡πâ‡∏≤‡∏ô‡∏Å‡∏é‡∏£‡∏∞‡πÄ‡∏ö‡∏µ‡∏¢‡∏ö

### 8.1 Ministry of Public Health Requirements

**‡∏Ç‡πâ‡∏≠‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡∏Ç‡∏≠‡∏á‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏™‡∏≤‡∏ò‡∏≤‡∏£‡∏ì‡∏™‡∏∏‡∏Ç**

**DMSIC Standards ‡∏û.‡∏®. 2568:**

- ‚úÖ 100% compliance with 79 required fields across 5 export files
- ‚úÖ ‡∏™‡∏≠‡∏î‡∏Ñ‡∏•‡πâ‡∏≠‡∏á‡∏Ñ‡∏£‡∏ö 100% ‡∏Å‡∏±‡∏ö‡∏ü‡∏¥‡∏•‡∏î‡πå‡∏ó‡∏µ‡πà‡∏Å‡∏≥‡∏´‡∏ô‡∏î 79 ‡∏ü‡∏¥‡∏•‡∏î‡πå‡πÉ‡∏ô 5 ‡πÑ‡∏ü‡∏•‡πå‡∏™‡πà‡∏á‡∏≠‡∏≠‡∏Å

**Required Export Files:**

1. **DRUGLIST** - Drug Catalog (11 fields)
   - Drug code, name, manufacturer, NLEM status, etc.
   - ‡∏£‡∏´‡∏±‡∏™‡∏¢‡∏≤, ‡∏ä‡∏∑‡πà‡∏≠, ‡∏ú‡∏π‡πâ‡∏ú‡∏•‡∏¥‡∏ï, ‡∏™‡∏ñ‡∏≤‡∏ô‡∏∞ NLEM ‡πÄ‡∏õ‡πá‡∏ô‡∏ï‡πâ‡∏ô

2. **PURCHASEPLAN** - Purchase Planning (20 fields)
   - Annual/quarterly purchase planning data
   - ‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏Å‡∏≤‡∏£‡∏ß‡∏≤‡∏á‡πÅ‡∏ú‡∏ô‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠‡∏£‡∏≤‡∏¢‡∏õ‡∏µ/‡∏£‡∏≤‡∏¢‡πÑ‡∏ï‡∏£‡∏°‡∏≤‡∏™

3. **RECEIPT** - Goods Receiving (22 fields)
   - Receipt details, lot information, expiry dates
   - ‡∏£‡∏≤‡∏¢‡∏•‡∏∞‡πÄ‡∏≠‡∏µ‡∏¢‡∏î‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏ö‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤, ‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏•‡πá‡∏≠‡∏ï, ‡∏ß‡∏±‡∏ô‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏

4. **DISTRIBUTION** - Drug Distribution (11 fields)
   - Distribution to departments/wards
   - ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢‡πÉ‡∏´‡πâ‡πÅ‡∏ú‡∏ô‡∏Å/‡∏´‡∏≠‡∏ú‡∏π‡πâ‡∏õ‡πà‡∏ß‡∏¢

5. **INVENTORY** - Stock Status (15 fields)
   - Current inventory levels by location
   - ‡∏£‡∏∞‡∏î‡∏±‡∏ö‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô‡∏à‡∏≥‡πÅ‡∏ô‡∏Å‡∏ï‡∏≤‡∏°‡∏™‡∏ñ‡∏≤‡∏ô‡∏ó‡∏µ‡πà

**TMT Integration:**

- Support Thai Medical Terminology (TMT) code mapping
- ‡∏£‡∏≠‡∏á‡∏£‡∏±‡∏ö‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡πÇ‡∏¢‡∏á‡∏£‡∏´‡∏±‡∏™‡∏®‡∏±‡∏û‡∏ó‡πå‡∏ó‡∏≤‡∏á‡∏Å‡∏≤‡∏£‡πÅ‡∏û‡∏ó‡∏¢‡πå‡πÑ‡∏ó‡∏¢ (TMT)
- 25,991 TMT concepts in database
- ‡∏°‡∏µ 25,991 ‡πÅ‡∏ô‡∏ß‡∏Ñ‡∏¥‡∏î TMT ‡πÉ‡∏ô‡∏ê‡∏≤‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•

### 8.2 Financial Regulations

**‡∏Ç‡πâ‡∏≠‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡∏î‡πâ‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏á‡∏¥‡∏ô**

**Budget Control:**

- Comply with Government Budget Act B.E. 2561
- ‡∏õ‡∏è‡∏¥‡∏ö‡∏±‡∏ï‡∏¥‡∏ï‡∏≤‡∏°‡∏û‡∏£‡∏∞‡∏£‡∏≤‡∏ä‡∏ö‡∏±‡∏ç‡∏ç‡∏±‡∏ï‡∏¥‡∏ß‡∏¥‡∏ò‡∏µ‡∏Å‡∏≤‡∏£‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì ‡∏û.‡∏®. 2561
- Fiscal year: October 1 - September 30
- ‡∏õ‡∏µ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì: 1 ‡∏ï‡∏∏‡∏•‡∏≤‡∏Ñ‡∏° - 30 ‡∏Å‡∏±‡∏ô‡∏¢‡∏≤‡∏¢‡∏ô

**Procurement Regulations:**

- Follow Procurement Regulations B.E. 2560
- ‡∏õ‡∏è‡∏¥‡∏ö‡∏±‡∏ï‡∏¥‡∏ï‡∏≤‡∏°‡∏£‡∏∞‡πÄ‡∏ö‡∏µ‡∏¢‡∏ö‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏Å‡∏≤‡∏£‡∏Ñ‡∏•‡∏±‡∏á‡∏ß‡πà‡∏≤‡∏î‡πâ‡∏ß‡∏¢‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠‡∏à‡∏±‡∏î‡∏à‡πâ‡∏≤‡∏á ‡∏û.‡∏®. 2560
- Maintain complete audit trail
- ‡∏£‡∏±‡∏Å‡∏©‡∏≤‡∏£‡πà‡∏≠‡∏á‡∏£‡∏≠‡∏¢‡∏Å‡∏≤‡∏£‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡∏ó‡∏µ‡πà‡∏™‡∏°‡∏ö‡∏π‡∏£‡∏ì‡πå

### 8.3 Data Protection (PDPA)

**‡∏Å‡∏≤‡∏£‡∏Ñ‡∏∏‡πâ‡∏°‡∏Ñ‡∏£‡∏≠‡∏á‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏™‡πà‡∏ß‡∏ô‡∏ö‡∏∏‡∏Ñ‡∏Ñ‡∏•**

**Personal Data Protection Act B.E. 2562:**

- Protect employee and vendor personal data
- ‡∏õ‡∏Å‡∏õ‡πâ‡∏≠‡∏á‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏™‡πà‡∏ß‡∏ô‡∏ö‡∏∏‡∏Ñ‡∏Ñ‡∏•‡∏Ç‡∏≠‡∏á‡∏û‡∏ô‡∏±‡∏Å‡∏á‡∏≤‡∏ô‡πÅ‡∏•‡∏∞‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢
- Implement proper access controls
- ‡πÉ‡∏ä‡πâ‡∏°‡∏≤‡∏ï‡∏£‡∏Å‡∏≤‡∏£‡∏Ñ‡∏ß‡∏ö‡∏Ñ‡∏∏‡∏°‡∏Å‡∏≤‡∏£‡πÄ‡∏Ç‡πâ‡∏≤‡∏ñ‡∏∂‡∏á‡∏ó‡∏µ‡πà‡πÄ‡∏´‡∏°‡∏≤‡∏∞‡∏™‡∏°
- Maintain data processing records
- ‡∏à‡∏±‡∏î‡πÄ‡∏Å‡πá‡∏ö‡∏ö‡∏±‡∏ô‡∏ó‡∏∂‡∏Å‡∏Å‡∏≤‡∏£‡∏õ‡∏£‡∏∞‡∏°‡∏ß‡∏•‡∏ú‡∏•‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•

### 8.4 Audit Requirements

**‡∏Ç‡πâ‡∏≠‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡∏Å‡∏≤‡∏£‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö**

**Audit Trail:**

- Record all transactions with timestamp and user
- ‡∏ö‡∏±‡∏ô‡∏ó‡∏∂‡∏Å‡∏ò‡∏∏‡∏£‡∏Å‡∏£‡∏£‡∏°‡∏ó‡∏±‡πâ‡∏á‡∏´‡∏°‡∏î‡∏û‡∏£‡πâ‡∏≠‡∏°‡πÄ‡∏ß‡∏•‡∏≤‡πÅ‡∏•‡∏∞‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ
- Log all approval actions
- ‡∏ö‡∏±‡∏ô‡∏ó‡∏∂‡∏Å‡∏Å‡∏≤‡∏£‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥‡∏ó‡∏±‡πâ‡∏á‡∏´‡∏°‡∏î
- Maintain change history for critical data
- ‡∏à‡∏±‡∏î‡πÄ‡∏Å‡πá‡∏ö‡∏õ‡∏£‡∏∞‡∏ß‡∏±‡∏ï‡∏¥‡∏Å‡∏≤‡∏£‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡πÅ‡∏õ‡∏•‡∏á‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç

**Document Retention:**

- Keep transaction records for 10 years
- ‡πÄ‡∏Å‡πá‡∏ö‡∏£‡∏±‡∏Å‡∏©‡∏≤‡∏ö‡∏±‡∏ô‡∏ó‡∏∂‡∏Å‡∏ò‡∏∏‡∏£‡∏Å‡∏£‡∏£‡∏° 10 ‡∏õ‡∏µ
- Maintain budget documents per fiscal year
- ‡∏à‡∏±‡∏î‡πÄ‡∏Å‡πá‡∏ö‡πÄ‡∏≠‡∏Å‡∏™‡∏≤‡∏£‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏ï‡∏≤‡∏°‡∏õ‡∏µ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì

---

## 9. User Roles and Permissions | ‡∏ö‡∏ó‡∏ö‡∏≤‡∏ó‡πÅ‡∏•‡∏∞‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡πå‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ

### 9.1 Role Definitions | ‡∏Ñ‡∏≥‡∏à‡∏≥‡∏Å‡∏±‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡∏Ç‡∏≠‡∏á‡∏ö‡∏ó‡∏ö‡∏≤‡∏ó

#### System Administrator | ‡∏ú‡∏π‡πâ‡∏î‡∏π‡πÅ‡∏•‡∏£‡∏∞‡∏ö‡∏ö

**Responsibilities | ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏±‡∏ö‡∏ú‡∏¥‡∏î‡∏ä‡∏≠‡∏ö:**

- System configuration and maintenance
- ‡∏Å‡∏≤‡∏£‡∏ï‡∏±‡πâ‡∏á‡∏Ñ‡πà‡∏≤‡πÅ‡∏•‡∏∞‡∏ö‡∏≥‡∏£‡∏∏‡∏á‡∏£‡∏±‡∏Å‡∏©‡∏≤‡∏£‡∏∞‡∏ö‡∏ö
- User management
- ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ
- Master data setup
- ‡∏Å‡∏≤‡∏£‡∏ï‡∏±‡πâ‡∏á‡∏Ñ‡πà‡∏≤‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏´‡∏•‡∏±‡∏Å

**Permissions | ‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡πå:**

- ‚úÖ Full access to all modules
- ‚úÖ Manage users and roles
- ‚úÖ Configure system settings
- ‚úÖ View audit logs

#### Pharmacy Manager | ‡∏´‡∏±‡∏ß‡∏´‡∏ô‡πâ‡∏≤‡πÄ‡∏†‡∏™‡∏±‡∏ä‡∏Å‡∏£‡∏£‡∏°

**Responsibilities | ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏±‡∏ö‡∏ú‡∏¥‡∏î‡∏ä‡∏≠‡∏ö:**

- Drug catalog management
- ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏£‡∏≤‡∏¢‡∏Å‡∏≤‡∏£‡∏¢‡∏≤
- Purchase request approval
- ‡∏Å‡∏≤‡∏£‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠
- Inventory oversight
- ‡∏Å‡∏≤‡∏£‡∏î‡∏π‡πÅ‡∏•‡∏™‡∏ï‡πá‡∏≠‡∏Å

**Permissions | ‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡πå:**

- ‚úÖ Approve purchase requests
- ‚úÖ Manage drug catalog
- ‚úÖ View all inventory reports
- ‚úÖ Configure inventory parameters

#### Pharmacist | ‡πÄ‡∏†‡∏™‡∏±‡∏ä‡∏Å‡∏£

**Responsibilities | ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏±‡∏ö‡∏ú‡∏¥‡∏î‡∏ä‡∏≠‡∏ö:**

- Goods receiving
- ‡∏Å‡∏≤‡∏£‡∏£‡∏±‡∏ö‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤
- Drug distribution
- ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤
- Inventory management
- ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏ï‡πá‡∏≠‡∏Å

**Permissions | ‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡πå:**

- ‚úÖ Receive goods
- ‚úÖ Create distribution orders
- ‚úÖ View inventory
- ‚úÖ Adjust inventory (with approval)

#### Procurement Officer | ‡πÄ‡∏à‡πâ‡∏≤‡∏´‡∏ô‡πâ‡∏≤‡∏ó‡∏µ‡πà‡∏û‡∏±‡∏™‡∏î‡∏∏

**Responsibilities | ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏±‡∏ö‡∏ú‡∏¥‡∏î‡∏ä‡∏≠‡∏ö:**

- Create purchase requests
- ‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠
- Generate purchase orders
- ‡∏™‡∏£‡πâ‡∏≤‡∏á‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠
- Vendor management
- ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢

**Permissions | ‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡πå:**

- ‚úÖ Create and edit purchase requests
- ‚úÖ Create purchase orders
- ‚úÖ Manage vendor information
- ‚úÖ View budget availability

#### Finance Officer | ‡πÄ‡∏à‡πâ‡∏≤‡∏´‡∏ô‡πâ‡∏≤‡∏ó‡∏µ‡πà‡∏Å‡∏≤‡∏£‡πÄ‡∏á‡∏¥‡∏ô

**Responsibilities | ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏±‡∏ö‡∏ú‡∏¥‡∏î‡∏ä‡∏≠‡∏ö:**

- Budget management
- ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì
- Budget approval
- ‡∏Å‡∏≤‡∏£‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì
- Financial reporting
- ‡∏Å‡∏≤‡∏£‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡∏ó‡∏≤‡∏á‡∏Å‡∏≤‡∏£‡πÄ‡∏á‡∏¥‡∏ô

**Permissions | ‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡πå:**

- ‚úÖ Create budget allocations
- ‚úÖ Approve budget requests
- ‚úÖ View financial reports
- ‚úÖ Monitor budget utilization

#### Department Staff | ‡πÄ‡∏à‡πâ‡∏≤‡∏´‡∏ô‡πâ‡∏≤‡∏ó‡∏µ‡πà‡πÅ‡∏ú‡∏ô‡∏Å

**Responsibilities | ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏£‡∏±‡∏ö‡∏ú‡∏¥‡∏î‡∏ä‡∏≠‡∏ö:**

- Request drug distribution
- ‡∏Ç‡∏≠‡∏à‡∏±‡∏î‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤
- View department inventory
- ‡∏î‡∏π‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏Ç‡∏≠‡∏á‡πÅ‡∏ú‡∏ô‡∏Å

**Permissions | ‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡πå:**

- ‚úÖ Create distribution requests
- ‚úÖ View department stock
- üö´ Cannot approve or receive goods

### 9.2 Permission Matrix | ‡∏ï‡∏≤‡∏£‡∏≤‡∏á‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡πå‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô

| Function             | Admin | Pharmacy Manager | Pharmacist | Procurement | Finance | Dept Staff |
| -------------------- | ----- | ---------------- | ---------- | ----------- | ------- | ---------- |
| User Management      | ‚úÖ    | üö´               | üö´         | üö´          | üö´      | üö´         |
| Drug Catalog         | ‚úÖ    | ‚úÖ               | üëÅÔ∏è         | üëÅÔ∏è          | üëÅÔ∏è      | üëÅÔ∏è         |
| Create PR            | ‚úÖ    | ‚úÖ               | ‚úÖ         | ‚úÖ          | üö´      | üö´         |
| Approve PR           | ‚úÖ    | ‚úÖ               | üö´         | üö´          | ‚úÖ      | üö´         |
| Create PO            | ‚úÖ    | ‚úÖ               | üö´         | ‚úÖ          | üö´      | üö´         |
| Receive Goods        | ‚úÖ    | ‚úÖ               | ‚úÖ         | üö´          | üö´      | üö´         |
| Distribute Drugs     | ‚úÖ    | ‚úÖ               | ‚úÖ         | üö´          | üö´      | üö´         |
| Request Distribution | ‚úÖ    | ‚úÖ               | ‚úÖ         | üö´          | üö´      | ‚úÖ         |
| Budget Allocation    | ‚úÖ    | üö´               | üö´         | üö´          | ‚úÖ      | üö´         |
| View Reports         | ‚úÖ    | ‚úÖ               | üëÅÔ∏è         | üëÅÔ∏è          | ‚úÖ      | üëÅÔ∏è         |

**Legend:**

- ‚úÖ = Full Access (‡πÄ‡∏Ç‡πâ‡∏≤‡∏ñ‡∏∂‡∏á‡πÑ‡∏î‡πâ‡πÄ‡∏ï‡πá‡∏°‡∏£‡∏π‡∏õ‡πÅ‡∏ö‡∏ö)
- üëÅÔ∏è = View Only (‡∏î‡∏π‡πÑ‡∏î‡πâ‡∏≠‡∏¢‡πà‡∏≤‡∏á‡πÄ‡∏î‡∏µ‡∏¢‡∏ß)
- üö´ = No Access (‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡πå)

---

## 10. Success Criteria | ‡πÄ‡∏Å‡∏ì‡∏ë‡πå‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡πÄ‡∏£‡πá‡∏à

### 10.1 Technical Success Criteria

**‡πÄ‡∏Å‡∏ì‡∏ë‡πå‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡πÄ‡∏£‡πá‡∏à‡∏î‡πâ‡∏≤‡∏ô‡πÄ‡∏ó‡∏Ñ‡∏ô‡∏¥‡∏Ñ**

**System Performance:**

- ‚ö° Page load time < 2 seconds
- ‚ö° ‡πÄ‡∏ß‡∏•‡∏≤‡πÇ‡∏´‡∏•‡∏î‡∏´‡∏ô‡πâ‡∏≤‡∏à‡∏≠ < 2 ‡∏ß‡∏¥‡∏ô‡∏≤‡∏ó‡∏µ
- ‚ö° API response time < 500ms for 95% of requests
- ‚ö° ‡πÄ‡∏ß‡∏•‡∏≤‡∏ï‡∏≠‡∏ö‡∏™‡∏ô‡∏≠‡∏á API < 500 ‡∏°‡∏¥‡∏•‡∏•‡∏¥‡∏ß‡∏¥‡∏ô‡∏≤‡∏ó‡∏µ‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö 95% ‡∏Ç‡∏≠‡∏á‡∏Ñ‡∏≥‡∏Ç‡∏≠
- ‚ö° System uptime > 99.5%
- ‚ö° ‡∏£‡∏∞‡∏ö‡∏ö‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô‡πÑ‡∏î‡πâ > 99.5% ‡∏Ç‡∏≠‡∏á‡πÄ‡∏ß‡∏•‡∏≤

**Data Accuracy:**

- ‚úÖ 100% accuracy in ministry export files
- ‚úÖ ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ñ‡∏π‡∏Å‡∏ï‡πâ‡∏≠‡∏á 100% ‡πÉ‡∏ô‡πÑ‡∏ü‡∏•‡πå‡∏™‡πà‡∏á‡∏≠‡∏≠‡∏Å‡πÉ‡∏´‡πâ‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á
- ‚úÖ Zero negative stock balances
- ‚úÖ ‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏¢‡∏≠‡∏î‡∏Ñ‡∏á‡πÄ‡∏´‡∏•‡∏∑‡∏≠‡∏ï‡∏¥‡∏î‡∏•‡∏ö
- ‚úÖ Budget calculation accuracy > 99.99%
- ‚úÖ ‡∏Ñ‡∏ß‡∏≤‡∏°‡πÅ‡∏°‡πà‡∏ô‡∏¢‡∏≥‡∏Å‡∏≤‡∏£‡∏Ñ‡∏≥‡∏ô‡∏ß‡∏ì‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì > 99.99%

**Security:**

- üîê All sensitive data encrypted at rest and in transit
- üîê ‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏ó‡∏±‡πâ‡∏á‡∏´‡∏°‡∏î‡πÄ‡∏Ç‡πâ‡∏≤‡∏£‡∏´‡∏±‡∏™‡∏ó‡∏±‡πâ‡∏á‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡πÄ‡∏Å‡πá‡∏ö‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏™‡πà‡∏á‡∏ú‡πà‡∏≤‡∏ô
- üîê Role-based access control implemented
- üîê ‡πÉ‡∏ä‡πâ‡∏Å‡∏≤‡∏£‡∏Ñ‡∏ß‡∏ö‡∏Ñ‡∏∏‡∏°‡∏Å‡∏≤‡∏£‡πÄ‡∏Ç‡πâ‡∏≤‡∏ñ‡∏∂‡∏á‡∏ï‡∏≤‡∏°‡∏ö‡∏ó‡∏ö‡∏≤‡∏ó
- üîê Complete audit trail for all transactions
- üîê ‡∏°‡∏µ‡∏£‡πà‡∏≠‡∏á‡∏£‡∏≠‡∏¢‡∏Å‡∏≤‡∏£‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡∏Ñ‡∏£‡∏ö‡∏ñ‡πâ‡∏ß‡∏ô‡∏ó‡∏∏‡∏Å‡∏ò‡∏∏‡∏£‡∏Å‡∏£‡∏£‡∏°

### 10.2 Business Success Criteria

**‡πÄ‡∏Å‡∏ì‡∏ë‡πå‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡πÄ‡∏£‡πá‡∏à‡∏î‡πâ‡∏≤‡∏ô‡∏ò‡∏∏‡∏£‡∏Å‡∏¥‡∏à**

**Operational Efficiency:**

- üìà 50% reduction in PR processing time (from 3 days to 1.5 days)
- üìà ‡∏•‡∏î‡πÄ‡∏ß‡∏•‡∏≤‡∏õ‡∏£‡∏∞‡∏°‡∏ß‡∏•‡∏ú‡∏•‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠‡∏•‡∏á 50% (‡∏à‡∏≤‡∏Å 3 ‡∏ß‡∏±‡∏ô ‡πÄ‡∏´‡∏•‡∏∑‡∏≠ 1.5 ‡∏ß‡∏±‡∏ô)
- üìà 30% reduction in drug expiry waste
- üìà ‡∏•‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏π‡∏ç‡πÄ‡∏™‡∏µ‡∏¢‡∏à‡∏≤‡∏Å‡∏¢‡∏≤‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏•‡∏á 30%
- üìà 20% improvement in budget utilization
- üìà ‡πÄ‡∏û‡∏¥‡πà‡∏°‡∏õ‡∏£‡∏∞‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡∏†‡∏≤‡∏û‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏Ç‡∏∂‡πâ‡∏ô 20%

**Compliance:**

- ‚úÖ 100% on-time ministry report submission
- ‚úÖ ‡∏™‡πà‡∏á‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡πÉ‡∏´‡πâ‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏ï‡∏£‡∏á‡πÄ‡∏ß‡∏•‡∏≤ 100%
- ‚úÖ Zero compliance violations
- ‚úÖ ‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏Å‡∏≤‡∏£‡∏ù‡πà‡∏≤‡∏ù‡∏∑‡∏ô‡∏Å‡∏é‡∏£‡∏∞‡πÄ‡∏ö‡∏µ‡∏¢‡∏ö
- ‚úÖ Pass external audit with no major findings
- ‚úÖ ‡∏ú‡πà‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡∏ï‡∏£‡∏ß‡∏à‡∏™‡∏≠‡∏ö‡∏à‡∏≤‡∏Å‡∏†‡∏≤‡∏¢‡∏ô‡∏≠‡∏Å‡πÇ‡∏î‡∏¢‡πÑ‡∏°‡πà‡∏°‡∏µ‡∏Ç‡πâ‡∏≠‡∏ö‡∏Å‡∏û‡∏£‡πà‡∏≠‡∏á‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç

**User Adoption:**

- üë• 80% user adoption within 3 months
- üë• ‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ 80% ‡πÄ‡∏£‡∏¥‡πà‡∏°‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô‡∏†‡∏≤‡∏¢‡πÉ‡∏ô 3 ‡πÄ‡∏î‡∏∑‡∏≠‡∏ô
- üë• User satisfaction score > 4.0/5.0
- üë• ‡∏Ñ‡∏∞‡πÅ‡∏ô‡∏ô‡∏Ñ‡∏ß‡∏≤‡∏°‡∏û‡∏∂‡∏á‡∏û‡∏≠‡πÉ‡∏à‡∏Ç‡∏≠‡∏á‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ > 4.0/5.0
- üë• < 5 support tickets per week after 3 months
- üë• < 5 ‡∏Ñ‡∏≥‡∏£‡πâ‡∏≠‡∏á‡∏Ç‡∏≠‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ä‡πà‡∏ß‡∏¢‡πÄ‡∏´‡∏•‡∏∑‡∏≠‡∏ï‡πà‡∏≠‡∏™‡∏±‡∏õ‡∏î‡∏≤‡∏´‡πå‡∏´‡∏•‡∏±‡∏á 3 ‡πÄ‡∏î‡∏∑‡∏≠‡∏ô

**Cost Savings:**

- üí∞ 500,000-1,000,000 THB/year reduction in expired drug waste
- üí∞ ‡∏•‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏π‡∏ç‡πÄ‡∏™‡∏µ‡∏¢‡∏à‡∏≤‡∏Å‡∏¢‡∏≤‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏ 500,000-1,000,000 ‡∏ö‡∏≤‡∏ó/‡∏õ‡∏µ
- üí∞ 100,000 THB/year reduction in manual report preparation
- üí∞ ‡∏•‡∏î‡∏Ñ‡πà‡∏≤‡πÉ‡∏ä‡πâ‡∏à‡πà‡∏≤‡∏¢‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏ó‡∏≥‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡∏î‡πâ‡∏ß‡∏¢‡∏°‡∏∑‡∏≠ 100,000 ‡∏ö‡∏≤‡∏ó/‡∏õ‡∏µ

---

## 11. Assumptions and Constraints | ‡∏™‡∏°‡∏°‡∏ï‡∏¥‡∏ê‡∏≤‡∏ô‡πÅ‡∏•‡∏∞‡∏Ç‡πâ‡∏≠‡∏à‡∏≥‡∏Å‡∏±‡∏î

### 11.1 Assumptions | ‡∏™‡∏°‡∏°‡∏ï‡∏¥‡∏ê‡∏≤‡∏ô

**Technical Assumptions:**

- Users have modern web browsers (Chrome, Firefox, Safari, Edge)
- ‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ‡∏°‡∏µ‡πÄ‡∏ß‡πá‡∏ö‡πÄ‡∏ö‡∏£‡∏≤‡∏ß‡πå‡πÄ‡∏ã‡∏≠‡∏£‡πå‡∏£‡∏∏‡πà‡∏ô‡πÉ‡∏´‡∏°‡πà (Chrome, Firefox, Safari, Edge)
- Internet connectivity available at all work locations
- ‡∏°‡∏µ‡∏≠‡∏¥‡∏ô‡πÄ‡∏ó‡∏≠‡∏£‡πå‡πÄ‡∏ô‡πá‡∏ï‡∏ó‡∏µ‡πà‡∏™‡∏ñ‡∏≤‡∏ô‡∏ó‡∏µ‡πà‡∏ó‡∏≥‡∏á‡∏≤‡∏ô‡∏ó‡∏∏‡∏Å‡πÅ‡∏´‡πà‡∏á
- PostgreSQL database server available
- ‡∏°‡∏µ‡πÄ‡∏ã‡∏¥‡∏£‡πå‡∏ü‡πÄ‡∏ß‡∏≠‡∏£‡πå‡∏ê‡∏≤‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏• PostgreSQL ‡∏û‡∏£‡πâ‡∏≠‡∏°‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô
- Docker infrastructure available for deployment
- ‡∏°‡∏µ‡πÇ‡∏Ñ‡∏£‡∏á‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏û‡∏∑‡πâ‡∏ô‡∏ê‡∏≤‡∏ô Docker ‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏Å‡∏≤‡∏£‡∏ï‡∏¥‡∏î‡∏ï‡∏±‡πâ‡∏á

**Business Assumptions:**

- Users will receive adequate training
- ‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ‡∏à‡∏∞‡πÑ‡∏î‡πâ‡∏£‡∏±‡∏ö‡∏Å‡∏≤‡∏£‡∏ù‡∏∂‡∏Å‡∏≠‡∏ö‡∏£‡∏°‡∏≠‡∏¢‡πà‡∏≤‡∏á‡πÄ‡∏û‡∏µ‡∏¢‡∏á‡∏û‡∏≠
- Legacy data can be migrated successfully
- ‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏¢‡πâ‡∏≤‡∏¢‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏à‡∏≤‡∏Å‡∏£‡∏∞‡∏ö‡∏ö‡πÄ‡∏î‡∏¥‡∏°‡πÑ‡∏î‡πâ‡∏™‡∏≥‡πÄ‡∏£‡πá‡∏à
- Vendors will continue using current communication methods
- ‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢‡∏à‡∏∞‡πÉ‡∏ä‡πâ‡∏ß‡∏¥‡∏ò‡∏µ‡∏Å‡∏≤‡∏£‡∏™‡∏∑‡πà‡∏≠‡∏™‡∏≤‡∏£‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô‡∏ï‡πà‡∏≠‡πÑ‡∏õ
- Ministry reporting requirements remain stable
- ‡∏Ç‡πâ‡∏≠‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡∏Å‡∏≤‡∏£‡∏£‡∏≤‡∏¢‡∏á‡∏≤‡∏ô‡πÉ‡∏´‡πâ‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏Ñ‡∏á‡∏ó‡∏µ‡πà

### 11.2 Constraints | ‡∏Ç‡πâ‡∏≠‡∏à‡∏≥‡∏Å‡∏±‡∏î

**Technical Constraints:**

- Must use existing hospital IT infrastructure
- ‡∏ï‡πâ‡∏≠‡∏á‡πÉ‡∏ä‡πâ‡πÇ‡∏Ñ‡∏£‡∏á‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏û‡∏∑‡πâ‡∏ô‡∏ê‡∏≤‡∏ô‡πÄ‡∏ó‡∏Ñ‡πÇ‡∏ô‡πÇ‡∏•‡∏¢‡∏µ‡∏™‡∏≤‡∏£‡∏™‡∏ô‡πÄ‡∏ó‡∏®‡∏Ç‡∏≠‡∏á‡πÇ‡∏£‡∏á‡∏û‡∏¢‡∏≤‡∏ö‡∏≤‡∏•‡∏ó‡∏µ‡πà‡∏°‡∏µ‡∏≠‡∏¢‡∏π‡πà
- Database schema cannot exceed 100 tables
- ‡πÇ‡∏Ñ‡∏£‡∏á‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏ê‡∏≤‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏ï‡πâ‡∏≠‡∏á‡πÑ‡∏°‡πà‡πÄ‡∏Å‡∏¥‡∏ô 100 ‡∏ï‡∏≤‡∏£‡∏≤‡∏á
- Must be compatible with Windows Server 2019+
- ‡∏ï‡πâ‡∏≠‡∏á‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏ó‡∏≥‡∏á‡∏≤‡∏ô‡∏£‡πà‡∏ß‡∏°‡∏Å‡∏±‡∏ö Windows Server 2019 ‡∏Ç‡∏∂‡πâ‡∏ô‡πÑ‡∏õ
- Response time must support 100 concurrent users
- ‡πÄ‡∏ß‡∏•‡∏≤‡∏ï‡∏≠‡∏ö‡∏™‡∏ô‡∏≠‡∏á‡∏ï‡πâ‡∏≠‡∏á‡∏£‡∏≠‡∏á‡∏£‡∏±‡∏ö‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ‡∏û‡∏£‡πâ‡∏≠‡∏°‡∏Å‡∏±‡∏ô 100 ‡∏Ñ‡∏ô

**Budget Constraints:**

- Limited development budget
- ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏Å‡∏≤‡∏£‡∏û‡∏±‡∏í‡∏ô‡∏≤‡∏°‡∏µ‡∏à‡∏≥‡∏Å‡∏±‡∏î
- Cannot purchase expensive third-party software
- ‡πÑ‡∏°‡πà‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡∏ã‡∏∑‡πâ‡∏≠‡∏ã‡∏≠‡∏ü‡∏ï‡πå‡πÅ‡∏ß‡∏£‡πå‡∏à‡∏≤‡∏Å‡∏ö‡∏£‡∏¥‡∏©‡∏±‡∏ó‡∏≠‡∏∑‡πà‡∏ô‡∏ó‡∏µ‡πà‡∏£‡∏≤‡∏Ñ‡∏≤‡πÅ‡∏û‡∏á‡πÑ‡∏î‡πâ
- Must use open-source technologies where possible
- ‡∏ï‡πâ‡∏≠‡∏á‡πÉ‡∏ä‡πâ‡πÄ‡∏ó‡∏Ñ‡πÇ‡∏ô‡πÇ‡∏•‡∏¢‡∏µ‡πÇ‡∏≠‡πÄ‡∏û‡∏ô‡∏ã‡∏≠‡∏£‡πå‡∏™‡πÄ‡∏ó‡πà‡∏≤‡∏ó‡∏µ‡πà‡πÄ‡∏õ‡πá‡∏ô‡πÑ‡∏õ‡πÑ‡∏î‡πâ

**Time Constraints:**

- Must complete Phase 1 (Database) before Q2 2025
- ‡∏ï‡πâ‡∏≠‡∏á‡πÄ‡∏™‡∏£‡πá‡∏à‡∏™‡∏¥‡πâ‡∏ô‡∏£‡∏∞‡∏¢‡∏∞‡∏ó‡∏µ‡πà 1 (‡∏ê‡∏≤‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•) ‡∏Å‡πà‡∏≠‡∏ô Q2 2025
- Full system must be operational by Q1 2026
- ‡∏£‡∏∞‡∏ö‡∏ö‡πÄ‡∏ï‡πá‡∏°‡∏£‡∏π‡∏õ‡πÅ‡∏ö‡∏ö‡∏ï‡πâ‡∏≠‡∏á‡∏û‡∏£‡πâ‡∏≠‡∏°‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô‡∏†‡∏≤‡∏¢‡πÉ‡∏ô Q1 2026

**Regulatory Constraints:**

- Must comply with all government regulations
- ‡∏ï‡πâ‡∏≠‡∏á‡∏õ‡∏è‡∏¥‡∏ö‡∏±‡∏ï‡∏¥‡∏ï‡∏≤‡∏°‡∏Å‡∏é‡∏£‡∏∞‡πÄ‡∏ö‡∏µ‡∏¢‡∏ö‡∏Ç‡∏≠‡∏á‡∏£‡∏±‡∏ê‡∏ö‡∏≤‡∏•‡∏ó‡∏±‡πâ‡∏á‡∏´‡∏°‡∏î
- Cannot modify ministry export file formats
- ‡πÑ‡∏°‡πà‡∏™‡∏≤‡∏°‡∏≤‡∏£‡∏ñ‡πÅ‡∏Å‡πâ‡πÑ‡∏Ç‡∏£‡∏π‡∏õ‡πÅ‡∏ö‡∏ö‡πÑ‡∏ü‡∏•‡πå‡∏™‡πà‡∏á‡∏≠‡∏≠‡∏Å‡πÉ‡∏´‡πâ‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡πÑ‡∏î‡πâ

---

## 12. Risks and Mitigation | ‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏ö‡∏£‡∏¥‡∏´‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£

### 12.1 High Risk | ‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡∏™‡∏π‡∏á

#### Risk 1: Data Migration Failure

**‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡∏ó‡∏µ‡πà 1: ‡∏Å‡∏≤‡∏£‡∏¢‡πâ‡∏≤‡∏¢‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏•‡πâ‡∏°‡πÄ‡∏´‡∏•‡∏ß**

**Description | ‡∏Ñ‡∏≥‡∏≠‡∏ò‡∏¥‡∏ö‡∏≤‡∏¢:**
Legacy data may have inconsistencies or missing values that prevent successful migration.

‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏à‡∏≤‡∏Å‡∏£‡∏∞‡∏ö‡∏ö‡πÄ‡∏î‡∏¥‡∏°‡∏≠‡∏≤‡∏à‡∏°‡∏µ‡∏Ñ‡∏ß‡∏≤‡∏°‡πÑ‡∏°‡πà‡∏™‡∏≠‡∏î‡∏Ñ‡∏•‡πâ‡∏≠‡∏á‡∏´‡∏£‡∏∑‡∏≠‡∏°‡∏µ‡∏Ñ‡πà‡∏≤‡∏ó‡∏µ‡πà‡∏Ç‡∏≤‡∏î‡∏´‡∏≤‡∏¢‡πÑ‡∏õ ‡∏ã‡∏∂‡πà‡∏á‡∏ó‡∏≥‡πÉ‡∏´‡πâ‡∏Å‡∏≤‡∏£‡∏¢‡πâ‡∏≤‡∏¢‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏•‡πâ‡∏°‡πÄ‡∏´‡∏•‡∏ß

**Impact | ‡∏ú‡∏•‡∏Å‡∏£‡∏∞‡∏ó‡∏ö:**

- ‚ö†Ô∏è Project delay of 1-2 months
- ‚ö†Ô∏è ‡πÇ‡∏Ñ‡∏£‡∏á‡∏Å‡∏≤‡∏£‡∏•‡πà‡∏≤‡∏ä‡πâ‡∏≤ 1-2 ‡πÄ‡∏î‡∏∑‡∏≠‡∏ô
- ‚ö†Ô∏è Incomplete drug catalog
- ‚ö†Ô∏è ‡∏£‡∏≤‡∏¢‡∏Å‡∏≤‡∏£‡∏¢‡∏≤‡πÑ‡∏°‡πà‡∏™‡∏°‡∏ö‡∏π‡∏£‡∏ì‡πå
- ‚ö†Ô∏è Missing historical data
- ‚ö†Ô∏è ‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏¢‡πâ‡∏≠‡∏ô‡∏´‡∏•‡∏±‡∏á‡∏™‡∏π‡∏ç‡∏´‡∏≤‡∏¢

**Mitigation | ‡∏Å‡∏≤‡∏£‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á:**

- ‚úÖ Perform data quality assessment before migration
- ‚úÖ ‡∏õ‡∏£‡∏∞‡πÄ‡∏°‡∏¥‡∏ô‡∏Ñ‡∏∏‡∏ì‡∏†‡∏≤‡∏û‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏Å‡πà‡∏≠‡∏ô‡∏ó‡∏≥‡∏Å‡∏≤‡∏£‡∏¢‡πâ‡∏≤‡∏¢
- ‚úÖ Create comprehensive data cleaning scripts
- ‚úÖ ‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏™‡∏Ñ‡∏£‡∏¥‡∏õ‡∏ï‡πå‡∏ó‡∏≥‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏∞‡∏≠‡∏≤‡∏î‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏Ñ‡∏£‡∏≠‡∏ö‡∏Ñ‡∏•‡∏∏‡∏°
- ‚úÖ Run pilot migration with sample data
- ‚úÖ ‡∏ó‡∏î‡∏•‡∏≠‡∏á‡∏¢‡πâ‡∏≤‡∏¢‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏ï‡∏±‡∏ß‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏Å‡πà‡∏≠‡∏ô
- ‚úÖ Have manual data entry backup plan
- ‚úÖ ‡∏°‡∏µ‡πÅ‡∏ú‡∏ô‡∏™‡∏≥‡∏£‡∏≠‡∏á‡∏Å‡∏≤‡∏£‡∏õ‡πâ‡∏≠‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏î‡πâ‡∏ß‡∏¢‡∏°‡∏∑‡∏≠

#### Risk 2: User Resistance

**‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡∏ó‡∏µ‡πà 2: ‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ‡∏ï‡πà‡∏≠‡∏ï‡πâ‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡πÅ‡∏õ‡∏•‡∏á**

**Description | ‡∏Ñ‡∏≥‡∏≠‡∏ò‡∏¥‡∏ö‡∏≤‡∏¢:**
Staff may resist adopting new system due to comfort with legacy system.

‡∏û‡∏ô‡∏±‡∏Å‡∏á‡∏≤‡∏ô‡∏≠‡∏≤‡∏à‡∏ï‡πà‡∏≠‡∏ï‡πâ‡∏≤‡∏ô‡∏Å‡∏≤‡∏£‡πÉ‡∏ä‡πâ‡∏£‡∏∞‡∏ö‡∏ö‡πÉ‡∏´‡∏°‡πà‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏Ñ‡∏∏‡πâ‡∏ô‡πÄ‡∏Ñ‡∏¢‡∏Å‡∏±‡∏ö‡∏£‡∏∞‡∏ö‡∏ö‡πÄ‡∏î‡∏¥‡∏°

**Impact | ‡∏ú‡∏•‡∏Å‡∏£‡∏∞‡∏ó‡∏ö:**

- ‚ö†Ô∏è Low user adoption rate
- ‚ö†Ô∏è ‡∏≠‡∏±‡∏ï‡∏£‡∏≤‡∏Å‡∏≤‡∏£‡∏¢‡∏≠‡∏°‡∏£‡∏±‡∏ö‡∏Ç‡∏≠‡∏á‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ‡∏ï‡πà‡∏≥
- ‚ö†Ô∏è Parallel use of old and new systems
- ‚ö†Ô∏è ‡πÉ‡∏ä‡πâ‡∏£‡∏∞‡∏ö‡∏ö‡πÄ‡∏Å‡πà‡∏≤‡πÅ‡∏•‡∏∞‡∏£‡∏∞‡∏ö‡∏ö‡πÉ‡∏´‡∏°‡πà‡∏Ñ‡∏ß‡∏ö‡∏Ñ‡∏π‡πà‡∏Å‡∏±‡∏ô
- ‚ö†Ô∏è Data entry errors
- ‚ö†Ô∏è ‡∏Ç‡πâ‡∏≠‡∏ú‡∏¥‡∏î‡∏û‡∏•‡∏≤‡∏î‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡∏õ‡πâ‡∏≠‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•

**Mitigation | ‡∏Å‡∏≤‡∏£‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á:**

- ‚úÖ Involve key users in design phase
- ‚úÖ ‡πÉ‡∏´‡πâ‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ‡∏´‡∏•‡∏±‡∏Å‡∏°‡∏µ‡∏™‡πà‡∏ß‡∏ô‡∏£‡πà‡∏ß‡∏°‡πÉ‡∏ô‡∏Ç‡∏±‡πâ‡∏ô‡∏ï‡∏≠‡∏ô‡∏Å‡∏≤‡∏£‡∏≠‡∏≠‡∏Å‡πÅ‡∏ö‡∏ö
- ‚úÖ Provide comprehensive training program
- ‚úÖ ‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏ù‡∏∂‡∏Å‡∏≠‡∏ö‡∏£‡∏°‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏Ñ‡∏£‡∏≠‡∏ö‡∏Ñ‡∏•‡∏∏‡∏°
- ‚úÖ Create user-friendly interface
- ‚úÖ ‡∏™‡∏£‡πâ‡∏≤‡∏á‡∏™‡πà‡∏ß‡∏ô‡∏ï‡∏¥‡∏î‡∏ï‡πà‡∏≠‡∏ú‡∏π‡πâ‡πÉ‡∏ä‡πâ‡∏ó‡∏µ‡πà‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô‡∏á‡πà‡∏≤‡∏¢
- ‚úÖ Have champions in each department
- ‚úÖ ‡∏°‡∏µ‡∏ú‡∏π‡πâ‡∏™‡∏ô‡∏±‡∏ö‡∏™‡∏ô‡∏∏‡∏ô‡πÉ‡∏ô‡πÅ‡∏ï‡πà‡∏•‡∏∞‡πÅ‡∏ú‡∏ô‡∏Å
- ‚úÖ Implement gradual rollout plan
- ‚úÖ ‡∏ô‡∏≥‡∏£‡∏∞‡∏ö‡∏ö‡πÑ‡∏õ‡πÉ‡∏ä‡πâ‡∏ó‡∏µ‡∏•‡∏∞‡∏Ç‡∏±‡πâ‡∏ô‡∏ï‡∏≠‡∏ô

#### Risk 3: Budget Overrun

**‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡∏ó‡∏µ‡πà 3: ‡πÉ‡∏ä‡πâ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡πÄ‡∏Å‡∏¥‡∏ô**

**Description | ‡∏Ñ‡∏≥‡∏≠‡∏ò‡∏¥‡∏ö‡∏≤‡∏¢:**
Project may exceed allocated budget due to scope creep or technical challenges.

‡πÇ‡∏Ñ‡∏£‡∏á‡∏Å‡∏≤‡∏£‡∏≠‡∏≤‡∏à‡πÉ‡∏ä‡πâ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡πÄ‡∏Å‡∏¥‡∏ô‡∏ó‡∏µ‡πà‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡πÄ‡∏ô‡∏∑‡πà‡∏≠‡∏á‡∏à‡∏≤‡∏Å‡∏Ç‡∏≠‡∏ö‡πÄ‡∏Ç‡∏ï‡∏Ç‡∏¢‡∏≤‡∏¢‡∏´‡∏£‡∏∑‡∏≠‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏ó‡∏≤‡∏á‡πÄ‡∏ó‡∏Ñ‡∏ô‡∏¥‡∏Ñ

**Impact | ‡∏ú‡∏•‡∏Å‡∏£‡∏∞‡∏ó‡∏ö:**

- ‚ö†Ô∏è Project delays or incomplete features
- ‚ö†Ô∏è ‡πÇ‡∏Ñ‡∏£‡∏á‡∏Å‡∏≤‡∏£‡∏•‡πà‡∏≤‡∏ä‡πâ‡∏≤‡∏´‡∏£‡∏∑‡∏≠‡∏ü‡∏µ‡πÄ‡∏à‡∏≠‡∏£‡πå‡πÑ‡∏°‡πà‡∏™‡∏°‡∏ö‡∏π‡∏£‡∏ì‡πå
- ‚ö†Ô∏è Additional budget requests required
- ‚ö†Ô∏è ‡∏ï‡πâ‡∏≠‡∏á‡∏Ç‡∏≠‡πÄ‡∏û‡∏¥‡πà‡∏°‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì

**Mitigation | ‡∏Å‡∏≤‡∏£‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á:**

- ‚úÖ Clear scope definition with priorities
- ‚úÖ ‡∏Å‡∏≥‡∏´‡∏ô‡∏î‡∏Ç‡∏≠‡∏ö‡πÄ‡∏Ç‡∏ï‡∏ó‡∏µ‡πà‡∏ä‡∏±‡∏î‡πÄ‡∏à‡∏ô‡∏û‡∏£‡πâ‡∏≠‡∏°‡∏•‡∏≥‡∏î‡∏±‡∏ö‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç
- ‚úÖ Regular budget monitoring
- ‚úÖ ‡∏ï‡∏¥‡∏î‡∏ï‡∏≤‡∏°‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏™‡∏°‡πà‡∏≥‡πÄ‡∏™‡∏°‡∏≠
- ‚úÖ Use agile approach for flexibility
- ‚úÖ ‡πÉ‡∏ä‡πâ‡∏ß‡∏¥‡∏ò‡∏µ‡∏Å‡∏≤‡∏£‡πÅ‡∏ö‡∏ö‡∏≠‡πÑ‡∏à‡∏•‡πå‡πÄ‡∏û‡∏∑‡πà‡∏≠‡∏Ñ‡∏ß‡∏≤‡∏°‡∏¢‡∏∑‡∏î‡∏´‡∏¢‡∏∏‡πà‡∏ô
- ‚úÖ Focus on must-have features first
- ‚úÖ ‡∏°‡∏∏‡πà‡∏á‡πÄ‡∏ô‡πâ‡∏ô‡∏ü‡∏µ‡πÄ‡∏à‡∏≠‡∏£‡πå‡∏ó‡∏µ‡πà‡∏à‡∏≥‡πÄ‡∏õ‡πá‡∏ô‡∏ï‡πâ‡∏≠‡∏á‡∏°‡∏µ‡∏Å‡πà‡∏≠‡∏ô

### 12.2 Medium Risk | ‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡∏õ‡∏≤‡∏ô‡∏Å‡∏•‡∏≤‡∏á

#### Risk 4: Integration Complexity

**‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡∏ó‡∏µ‡πà 4: ‡∏Ñ‡∏ß‡∏≤‡∏°‡∏ã‡∏±‡∏ö‡∏ã‡πâ‡∏≠‡∏ô‡πÉ‡∏ô‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡πÇ‡∏¢‡∏á**

**Description | ‡∏Ñ‡∏≥‡∏≠‡∏ò‡∏¥‡∏ö‡∏≤‡∏¢:**
Future integration with HIS or other systems may be more complex than anticipated.

‡∏Å‡∏≤‡∏£‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡πÇ‡∏¢‡∏á‡∏Å‡∏±‡∏ö HIS ‡∏´‡∏£‡∏∑‡∏≠‡∏£‡∏∞‡∏ö‡∏ö‡∏≠‡∏∑‡πà‡∏ô‡πÉ‡∏ô‡∏≠‡∏ô‡∏≤‡∏Ñ‡∏ï‡∏≠‡∏≤‡∏à‡∏ã‡∏±‡∏ö‡∏ã‡πâ‡∏≠‡∏ô‡∏Å‡∏ß‡πà‡∏≤‡∏ó‡∏µ‡πà‡∏Ñ‡∏≤‡∏î‡∏Å‡∏≤‡∏£‡∏ì‡πå

**Mitigation | ‡∏Å‡∏≤‡∏£‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á:**

- ‚úÖ Design with integration points in mind
- ‚úÖ ‡∏≠‡∏≠‡∏Å‡πÅ‡∏ö‡∏ö‡πÇ‡∏î‡∏¢‡∏Ñ‡∏≥‡∏ô‡∏∂‡∏á‡∏ñ‡∏∂‡∏á‡∏à‡∏∏‡∏î‡πÄ‡∏ä‡∏∑‡πà‡∏≠‡∏°‡πÇ‡∏¢‡∏á
- ‚úÖ Use standard APIs and data formats
- ‚úÖ ‡πÉ‡∏ä‡πâ API ‡πÅ‡∏•‡∏∞‡∏£‡∏π‡∏õ‡πÅ‡∏ö‡∏ö‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏°‡∏≤‡∏ï‡∏£‡∏ê‡∏≤‡∏ô
- ‚úÖ Document all interfaces thoroughly
- ‚úÖ ‡∏à‡∏±‡∏î‡∏ó‡∏≥‡πÄ‡∏≠‡∏Å‡∏™‡∏≤‡∏£‡∏≠‡∏¥‡∏ô‡πÄ‡∏ó‡∏≠‡∏£‡πå‡πÄ‡∏ü‡∏ã‡∏ó‡∏±‡πâ‡∏á‡∏´‡∏°‡∏î‡∏≠‡∏¢‡πà‡∏≤‡∏á‡∏•‡∏∞‡πÄ‡∏≠‡∏µ‡∏¢‡∏î

#### Risk 5: Performance Issues

**‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡∏ó‡∏µ‡πà 5: ‡∏õ‡∏±‡∏ç‡∏´‡∏≤‡∏î‡πâ‡∏≤‡∏ô‡∏õ‡∏£‡∏∞‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡∏†‡∏≤‡∏û**

**Description | ‡∏Ñ‡∏≥‡∏≠‡∏ò‡∏¥‡∏ö‡∏≤‡∏¢:**
System may experience slow performance with large data volumes.

‡∏£‡∏∞‡∏ö‡∏ö‡∏≠‡∏≤‡∏à‡∏ó‡∏≥‡∏á‡∏≤‡∏ô‡∏ä‡πâ‡∏≤‡πÄ‡∏°‡∏∑‡πà‡∏≠‡∏°‡∏µ‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏à‡∏≥‡∏ô‡∏ß‡∏ô‡∏°‡∏≤‡∏Å

**Mitigation | ‡∏Å‡∏≤‡∏£‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á:**

- ‚úÖ Implement proper database indexing
- ‚úÖ ‡πÉ‡∏ä‡πâ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ó‡∏≥‡∏î‡∏±‡∏ä‡∏ô‡∏µ‡∏ê‡∏≤‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏ó‡∏µ‡πà‡πÄ‡∏´‡∏°‡∏≤‡∏∞‡∏™‡∏°
- ‚úÖ Use caching strategies (Redis)
- ‚úÖ ‡πÉ‡∏ä‡πâ‡∏Å‡∏•‡∏¢‡∏∏‡∏ó‡∏ò‡πå‡πÅ‡∏Ñ‡∏ä (Redis)
- ‚úÖ Conduct load testing before go-live
- ‚úÖ ‡∏ó‡∏î‡∏™‡∏≠‡∏ö‡∏†‡∏≤‡∏£‡∏∞‡∏Å‡πà‡∏≠‡∏ô‡πÄ‡∏õ‡∏¥‡∏î‡πÉ‡∏ä‡πâ‡∏á‡∏≤‡∏ô‡∏à‡∏£‡∏¥‡∏á
- ‚úÖ Optimize SQL queries
- ‚úÖ ‡∏õ‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∏‡∏á‡∏Ñ‡∏≥‡∏™‡∏±‡πà‡∏á SQL ‡πÉ‡∏´‡πâ‡∏°‡∏µ‡∏õ‡∏£‡∏∞‡∏™‡∏¥‡∏ó‡∏ò‡∏¥‡∏†‡∏≤‡∏û

### 12.3 Low Risk | ‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡∏ï‡πà‡∏≥

#### Risk 6: Vendor Changes

**‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á‡∏ó‡∏µ‡πà 6: ‡∏Å‡∏≤‡∏£‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡πÅ‡∏õ‡∏•‡∏á‡∏Ç‡∏≠‡∏á‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢**

**Description | ‡∏Ñ‡∏≥‡∏≠‡∏ò‡∏¥‡∏ö‡∏≤‡∏¢:**
Vendors may change contact information or go out of business.

‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢‡∏≠‡∏≤‡∏à‡πÄ‡∏õ‡∏•‡∏µ‡πà‡∏¢‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏ï‡∏¥‡∏î‡∏ï‡πà‡∏≠‡∏´‡∏£‡∏∑‡∏≠‡∏õ‡∏¥‡∏î‡∏Å‡∏¥‡∏à‡∏Å‡∏≤‡∏£

**Mitigation | ‡∏Å‡∏≤‡∏£‡∏•‡∏î‡∏Ñ‡∏ß‡∏≤‡∏°‡πÄ‡∏™‡∏µ‡πà‡∏¢‡∏á:**

- ‚úÖ Maintain updated vendor database
- ‚úÖ ‡∏õ‡∏£‡∏±‡∏ö‡∏õ‡∏£‡∏∏‡∏á‡∏ê‡∏≤‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢‡πÉ‡∏´‡πâ‡πÄ‡∏õ‡πá‡∏ô‡∏õ‡∏±‡∏à‡∏à‡∏∏‡∏ö‡∏±‡∏ô
- ‚úÖ Allow soft deletion to preserve history
- ‚úÖ ‡∏≠‡∏ô‡∏∏‡∏ç‡∏≤‡∏ï‡πÉ‡∏´‡πâ‡∏•‡∏ö‡πÅ‡∏ö‡∏ö Soft ‡πÄ‡∏û‡∏∑‡πà‡∏≠‡∏£‡∏±‡∏Å‡∏©‡∏≤‡∏õ‡∏£‡∏∞‡∏ß‡∏±‡∏ï‡∏¥

---

## 13. Appendices | ‡∏†‡∏≤‡∏Ñ‡∏ú‡∏ô‡∏ß‡∏Å

### 13.1 Glossary | ‡∏≠‡∏†‡∏¥‡∏ò‡∏≤‡∏ô‡∏®‡∏±‡∏û‡∏ó‡πå

**ABC Analysis | ‡∏Å‡∏≤‡∏£‡∏ß‡∏¥‡πÄ‡∏Ñ‡∏£‡∏≤‡∏∞‡∏´‡πå ABC**

- Classification of drugs by value: A (high), B (medium), C (low)
- ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏•‡∏∏‡πà‡∏°‡∏¢‡∏≤‡∏ï‡∏≤‡∏°‡∏°‡∏π‡∏•‡∏Ñ‡πà‡∏≤: A (‡∏™‡∏π‡∏á), B (‡∏õ‡∏≤‡∏ô‡∏Å‡∏•‡∏≤‡∏á), C (‡∏ï‡πà‡∏≥)

**DMSIC (Drug and Medical Supply Information Center)**

- ‡∏Å‡∏£‡∏°‡∏ö‡∏±‡∏ç‡∏ä‡∏µ‡∏Å‡∏•‡∏≤‡∏á - Drug and Medical Supply Information Center
- ‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏Å‡∏≤‡∏£‡∏Ñ‡∏•‡∏±‡∏á - ‡∏®‡∏π‡∏ô‡∏¢‡πå‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏¢‡∏≤‡πÅ‡∏•‡∏∞‡πÄ‡∏ß‡∏ä‡∏†‡∏±‡∏ì‡∏ë‡πå

**FEFO (First Expire First Out)**

- Inventory management method that dispenses drugs with earliest expiry date first
- ‡∏ß‡∏¥‡∏ò‡∏µ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏ó‡∏µ‡πà‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤‡∏ó‡∏µ‡πà‡∏´‡∏°‡∏î‡∏≠‡∏≤‡∏¢‡∏∏‡∏Å‡πà‡∏≠‡∏ô‡∏≠‡∏≠‡∏Å‡∏Å‡πà‡∏≠‡∏ô

**FIFO (First In First Out)**

- Inventory management method that dispenses drugs received first
- ‡∏ß‡∏¥‡∏ò‡∏µ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏≤‡∏£‡∏™‡∏ï‡πá‡∏≠‡∏Å‡∏ó‡∏µ‡πà‡∏à‡πà‡∏≤‡∏¢‡∏¢‡∏≤‡∏ó‡∏µ‡πà‡πÄ‡∏Ç‡πâ‡∏≤‡∏°‡∏≤‡∏Å‡πà‡∏≠‡∏ô‡∏≠‡∏≠‡∏Å‡∏Å‡πà‡∏≠‡∏ô

**Fiscal Year | ‡∏õ‡∏µ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì**

- Budget year from October 1 to September 30
- ‡∏õ‡∏µ‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì‡∏ï‡∏±‡πâ‡∏á‡πÅ‡∏ï‡πà 1 ‡∏ï‡∏∏‡∏•‡∏≤‡∏Ñ‡∏° ‡∏ñ‡∏∂‡∏á 30 ‡∏Å‡∏±‡∏ô‡∏¢‡∏≤‡∏¢‡∏ô

**Generic Drug | ‡∏¢‡∏≤‡∏ä‡∏∑‡πà‡∏≠‡∏™‡∏≤‡∏°‡∏±‡∏ç**

- Drug identified by its active pharmaceutical ingredient (API)
- ‡∏¢‡∏≤‡∏ó‡∏µ‡πà‡∏£‡∏∞‡∏ö‡∏∏‡∏î‡πâ‡∏ß‡∏¢‡∏™‡πà‡∏ß‡∏ô‡∏ú‡∏™‡∏°‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏ó‡∏≤‡∏á‡∏¢‡∏≤ (API)

**HIS (Hospital Information System)**

- Comprehensive system managing all hospital operations
- ‡∏£‡∏∞‡∏ö‡∏ö‡∏™‡∏≤‡∏£‡∏™‡∏ô‡πÄ‡∏ó‡∏®‡πÇ‡∏£‡∏á‡∏û‡∏¢‡∏≤‡∏ö‡∏≤‡∏•‡πÅ‡∏ö‡∏ö‡∏Ñ‡∏£‡∏ö‡∏ß‡∏á‡∏à‡∏£

**Lot Number**

- Unique identifier for a batch of drugs from manufacturer
- ‡∏£‡∏´‡∏±‡∏™‡πÄ‡∏â‡∏û‡∏≤‡∏∞‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏¢‡∏≤‡πÅ‡∏ï‡πà‡∏•‡∏∞‡∏ä‡∏∏‡∏î‡∏à‡∏≤‡∏Å‡∏ú‡∏π‡πâ‡∏ú‡∏•‡∏¥‡∏ï

**NLEM (National List of Essential Medicines)**

- Government's list of essential drugs (E = Essential, N = Non-essential)
- ‡∏ö‡∏±‡∏ç‡∏ä‡∏µ‡∏¢‡∏≤‡∏´‡∏•‡∏±‡∏Å‡πÅ‡∏´‡πà‡∏á‡∏ä‡∏≤‡∏ï‡∏¥ (E = ‡∏à‡∏≥‡πÄ‡∏õ‡πá‡∏ô, N = ‡πÑ‡∏°‡πà‡∏à‡∏≥‡πÄ‡∏õ‡πá‡∏ô)

**PDPA (Personal Data Protection Act B.E. 2562)**

- Thai law protecting personal data privacy
- ‡∏û‡∏£‡∏∞‡∏£‡∏≤‡∏ä‡∏ö‡∏±‡∏ç‡∏ç‡∏±‡∏ï‡∏¥‡∏Ñ‡∏∏‡πâ‡∏°‡∏Ñ‡∏£‡∏≠‡∏á‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏™‡πà‡∏ß‡∏ô‡∏ö‡∏∏‡∏Ñ‡∏Ñ‡∏• ‡∏û.‡∏®. 2562

**PO (Purchase Order) | ‡πÉ‡∏ö‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠**

- Official order to vendor to supply goods
- ‡πÄ‡∏≠‡∏Å‡∏™‡∏≤‡∏£‡∏™‡∏±‡πà‡∏á‡∏ã‡∏∑‡πâ‡∏≠‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤‡∏≠‡∏¢‡πà‡∏≤‡∏á‡πÄ‡∏õ‡πá‡∏ô‡∏ó‡∏≤‡∏á‡∏Å‡∏≤‡∏£‡∏à‡∏≤‡∏Å‡∏ú‡∏π‡πâ‡∏à‡∏≥‡∏´‡∏ô‡πà‡∏≤‡∏¢

**PR (Purchase Request) | ‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏ã‡∏∑‡πâ‡∏≠**

- Internal request to procure goods
- ‡∏Ñ‡∏≥‡∏Ç‡∏≠‡∏†‡∏≤‡∏¢‡πÉ‡∏ô‡πÄ‡∏û‡∏∑‡πà‡∏≠‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠‡∏™‡∏¥‡∏ô‡∏Ñ‡πâ‡∏≤

**TMT (Thai Medical Terminology)**

- Standard medical terminology system in Thai language
- ‡∏£‡∏∞‡∏ö‡∏ö‡∏®‡∏±‡∏û‡∏ó‡πå‡∏ó‡∏≤‡∏á‡∏Å‡∏≤‡∏£‡πÅ‡∏û‡∏ó‡∏¢‡πå‡∏°‡∏≤‡∏ï‡∏£‡∏ê‡∏≤‡∏ô‡∏†‡∏≤‡∏©‡∏≤‡πÑ‡∏ó‡∏¢

**Trade Drug | ‡∏¢‡∏≤‡∏ä‡∏∑‡πà‡∏≠‡∏Å‡∏≤‡∏£‡∏Ñ‡πâ‡∏≤**

- Branded drug product from manufacturer
- ‡∏ú‡∏•‡∏¥‡∏ï‡∏†‡∏±‡∏ì‡∏ë‡πå‡∏¢‡∏≤‡∏ä‡∏∑‡πà‡∏≠‡∏Å‡∏≤‡∏£‡∏Ñ‡πâ‡∏≤‡∏à‡∏≤‡∏Å‡∏ú‡∏π‡πâ‡∏ú‡∏•‡∏¥‡∏ï

**VEN Analysis**

- Classification by criticality: V (Vital), E (Essential), N (Non-essential)
- ‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏Å‡∏•‡∏∏‡πà‡∏°‡∏ï‡∏≤‡∏°‡∏Ñ‡∏ß‡∏≤‡∏°‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç: V (‡∏™‡∏≥‡∏Ñ‡∏±‡∏ç‡∏¢‡∏¥‡πà‡∏á), E (‡∏à‡∏≥‡πÄ‡∏õ‡πá‡∏ô), N (‡πÑ‡∏°‡πà‡∏à‡∏≥‡πÄ‡∏õ‡πá‡∏ô)

### 13.2 References | ‡πÄ‡∏≠‡∏Å‡∏™‡∏≤‡∏£‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á

**Government Regulations:**

1. ‡∏û‡∏£‡∏∞‡∏£‡∏≤‡∏ä‡∏ö‡∏±‡∏ç‡∏ç‡∏±‡∏ï‡∏¥‡∏ß‡∏¥‡∏ò‡∏µ‡∏Å‡∏≤‡∏£‡∏á‡∏ö‡∏õ‡∏£‡∏∞‡∏°‡∏≤‡∏ì ‡∏û.‡∏®. 2561 (Government Budget Act B.E. 2561)
2. ‡∏£‡∏∞‡πÄ‡∏ö‡∏µ‡∏¢‡∏ö‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏Å‡∏≤‡∏£‡∏Ñ‡∏•‡∏±‡∏á‡∏ß‡πà‡∏≤‡∏î‡πâ‡∏ß‡∏¢‡∏Å‡∏≤‡∏£‡∏à‡∏±‡∏î‡∏ã‡∏∑‡πâ‡∏≠‡∏à‡∏±‡∏î‡∏à‡πâ‡∏≤‡∏á‡πÅ‡∏•‡∏∞‡∏Å‡∏≤‡∏£‡∏ö‡∏£‡∏¥‡∏´‡∏≤‡∏£‡∏û‡∏±‡∏™‡∏î‡∏∏‡∏†‡∏≤‡∏Ñ‡∏£‡∏±‡∏ê ‡∏û.‡∏®. 2560 (Procurement Regulations B.E. 2560)
3. ‡∏û‡∏£‡∏∞‡∏£‡∏≤‡∏ä‡∏ö‡∏±‡∏ç‡∏ç‡∏±‡∏ï‡∏¥‡∏Ñ‡∏∏‡πâ‡∏°‡∏Ñ‡∏£‡∏≠‡∏á‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏™‡πà‡∏ß‡∏ô‡∏ö‡∏∏‡∏Ñ‡∏Ñ‡∏• ‡∏û.‡∏®. 2562 (Personal Data Protection Act B.E. 2562)

**Ministry Standards:**

1. DMSIC Standards ‡∏û.‡∏®. 2568 - Drug and Medical Supply Information Standards
2. Thai Medical Terminology (TMT) - ‡∏®‡∏±‡∏û‡∏ó‡πå‡∏ó‡∏≤‡∏á‡∏Å‡∏≤‡∏£‡πÅ‡∏û‡∏ó‡∏¢‡πå‡πÑ‡∏ó‡∏¢
3. NLEM List - ‡∏ö‡∏±‡∏ç‡∏ä‡∏µ‡∏¢‡∏≤‡∏´‡∏•‡∏±‡∏Å‡πÅ‡∏´‡πà‡∏á‡∏ä‡∏≤‡∏ï‡∏¥

**Technical Documentation:**

1. PostgreSQL 15 Documentation
2. Prisma ORM Documentation
3. Angular 20 Documentation
4. Fastify 5 Documentation

**Project Documents:**

1. INVS Modern - README.md
2. INVS Modern - PROJECT_STATUS.md
3. INVS Modern - Technical Requirements Document (TRD)
4. INVS Modern - Database Design Documentation
5. Legacy INVS Manual Analysis

### 13.3 Document History | ‡∏õ‡∏£‡∏∞‡∏ß‡∏±‡∏ï‡∏¥‡πÄ‡∏≠‡∏Å‡∏™‡∏≤‡∏£

| Version | Date       | Author    | Changes                       |
| ------- | ---------- | --------- | ----------------------------- |
| 0.1     | 2025-01-15 | INVS Team | Initial draft                 |
| 0.2     | 2025-01-18 | INVS Team | Added compliance requirements |
| 1.0.0   | 2025-01-22 | INVS Team | Final version for review      |

### 13.4 Approval | ‡∏Å‡∏≤‡∏£‡∏≠‡∏ô‡∏∏‡∏°‡∏±‡∏ï‡∏¥

**Document Status:** Draft for Review | ‡∏£‡πà‡∏≤‡∏á‡∏™‡∏≥‡∏´‡∏£‡∏±‡∏ö‡∏û‡∏¥‡∏à‡∏≤‡∏£‡∏ì‡∏≤

**Approval Required From:**

- [ ] Hospital Director (‡∏ú‡∏π‡πâ‡∏≠‡∏≥‡∏ô‡∏ß‡∏¢‡∏Å‡∏≤‡∏£‡πÇ‡∏£‡∏á‡∏û‡∏¢‡∏≤‡∏ö‡∏≤‡∏•)
- [ ] Pharmacy Manager (‡∏´‡∏±‡∏ß‡∏´‡∏ô‡πâ‡∏≤‡πÄ‡∏†‡∏™‡∏±‡∏ä‡∏Å‡∏£‡∏£‡∏°)
- [ ] Finance Manager (‡∏´‡∏±‡∏ß‡∏´‡∏ô‡πâ‡∏≤‡∏Å‡∏≤‡∏£‡πÄ‡∏á‡∏¥‡∏ô)
- [ ] IT Manager (‡∏´‡∏±‡∏ß‡∏´‡∏ô‡πâ‡∏≤‡πÄ‡∏ó‡∏Ñ‡πÇ‡∏ô‡πÇ‡∏•‡∏¢‡∏µ‡∏™‡∏≤‡∏£‡∏™‡∏ô‡πÄ‡∏ó‡∏®)
- [ ] Procurement Manager (‡∏´‡∏±‡∏ß‡∏´‡∏ô‡πâ‡∏≤‡∏û‡∏±‡∏™‡∏î‡∏∏)

---

## Contact Information | ‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏Å‡∏≤‡∏£‡∏ï‡∏¥‡∏î‡∏ï‡πà‡∏≠

**Project Team:**

- Project Manager: [Name]
- Technical Lead: [Name]
- Business Analyst: [Name]

**For Questions or Feedback:**

- Email: invs-modern@hospital.go.th
- Phone: [TBD]
- Project Repository: /invs-modern

---

**END OF DOCUMENT | ‡∏™‡∏¥‡πâ‡∏ô‡∏™‡∏∏‡∏î‡πÄ‡∏≠‡∏Å‡∏™‡∏≤‡∏£**

_Document prepared using INVS Manual, legacy database analysis, and Ministry of Public Health standards_

_‡πÄ‡∏≠‡∏Å‡∏™‡∏≤‡∏£‡∏ô‡∏µ‡πâ‡∏à‡∏±‡∏î‡∏ó‡∏≥‡πÇ‡∏î‡∏¢‡∏≠‡πâ‡∏≤‡∏á‡∏≠‡∏¥‡∏á‡∏à‡∏≤‡∏Å‡∏Ñ‡∏π‡πà‡∏°‡∏∑‡∏≠ INVS, ‡∏Å‡∏≤‡∏£‡∏ß‡∏¥‡πÄ‡∏Ñ‡∏£‡∏≤‡∏∞‡∏´‡πå‡∏ê‡∏≤‡∏ô‡∏Ç‡πâ‡∏≠‡∏°‡∏π‡∏•‡∏£‡∏∞‡∏ö‡∏ö‡πÄ‡∏î‡∏¥‡∏° ‡πÅ‡∏•‡∏∞‡∏°‡∏≤‡∏ï‡∏£‡∏ê‡∏≤‡∏ô‡∏Ç‡∏≠‡∏á‡∏Å‡∏£‡∏∞‡∏ó‡∏£‡∏ß‡∏á‡∏™‡∏≤‡∏ò‡∏≤‡∏£‡∏ì‡∏™‡∏∏‡∏Ç_
